grepcent public filings, reorganized for comparison

GENWORTH FINANCIAL INC (GNW) FY 2022 MD&A

Verbatim Item 7 Management's Discussion and Analysis from GENWORTH FINANCIAL INC's 10-K for fiscal year 2022. Filing date: 2023-02-28. Report date: 2022-12-31. Accession: 0001193125-23-053994.

This page reproduces the company's own Item 7 MD&A text from the linked SEC filing. It is filer text, not grepcent analysis, scoring, or investment advice.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high.

Company profile: GNW · All MD&A years: index · Previous year: FY 2021 · Next year: FY 2023

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”

Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2022 and 2021. Discussions of information related to 2020 and year-to-year comparisons between 2021 and 2020 are not included in this Form 10-K. Comparative discussions between 2021 and 2020 can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2021.

Overview

Our business

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products which are no longer sold. We report our business results through three operating business segments: Enact; U.S. Life Insurance; and Runoff. We also have Corporate and Other activities. Our U.S. Life Insurance segment includes long-term care insurance, life insurance and fixed annuity products. The Runoff segment primarily includes variable annuity, variable life insurance and corporate-owned life insurance products, which have not been actively sold since 2011, as well as funding agreements.

Our financial information

The financial information in this Annual Report on Form 10-K has been derived from our consolidated financial statements.

Revenues and expenses

Our revenues consist primarily of the following:

Column 1Column 2Column 3Column 4
Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance.
Column 1Column 2Column 3Column 4
Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, unrealized and realized gains and losses from our equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Column 1Column 2Column 3Column 4
Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker/dealer commission revenues, fee revenue from contract underwriting services and other fees.

Our expenses consist primarily of the following:

Column 1Column 2Column 3Column 4
Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid and reserve activity related to current claims and future policy benefits on insurance and investment products for long-term care insurance, life insurance, accident and health insurance, structured settlements and single premium immediate annuities with life contingencies, and claim costs incurred related to mortgage insurance products.

80

Table of Contents

Column 1Column 2Column 3Column 4
Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances.
Column 1Column 2Column 3Column 4
Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses.
Column 1Column 2Column 3Column 4
Amortization of deferred acquisition costs and intangibles. Amortization of DAC and intangibles consists primarily of the amortization of acquisition costs that are capitalized, PVFP and capitalized software.
Column 1Column 2Column 3Column 4
Interest expense. Interest expense represents interest related to our borrowings that are incurred at Genworth Holdings or Enact Holdings and our former non-recourse funding obligations, as well as interest expense related to the Tax Matters Agreement previously owed to GE and certain reinsurance arrangements being accounted for as deposits.
Column 1Column 2Column 3Column 4
Income taxes. We tax our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities.
Column 1Column 2Column 3Column 4
Net income from continuing operations attributable to noncontrolling interests. Net income from continuing operations attributable to noncontrolling interests represents the portion of income from continuing operations in a subsidiary attributable to third parties.

The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.

We allocate corporate expenses to each of our operating segments using various methodologies.

81

Table of Contents

Consolidated Results of Operations

The following table sets forth the consolidated results of operations for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 20212021 vs. 2020
Revenues:
Premiums$3,719$3,435$3,836$2848%$(401)(10)%
Net investment income3,1463,3703,227(224)(7)%1434%
Net investment gains (losses)(17)323492(340)(105)%(169)(34)%
Policy fees and other income659704729(45)(6)%(25)(3)%
Total revenues7,5077,8328,284(325)(4)%(452)(5)%
Benefits and expenses:
Benefits and other changes in policy reserves4,2424,3835,214(141)(3)%(831)(16)%
Interest credited503508549(5)(1)%(41)(7)%
Acquisition and operating expenses, net of deferrals1,3711,22393514812%28831%
Amortization of deferred acquisition costs and intangibles307377463(70)(19)%(86)(19)%
Interest expense106160195(54)(34)%(35)(18)%
Total benefits and expenses6,5296,6517,356(122)(2)%(705)(10)%
Income from continuing operations before income taxes9781,181928(203)(17)%25327%
Provision for income taxes239263230(24)(9)%3314%
Income from continuing operations739918698(179)(19)%22032%
Income (loss) from discontinued operations, net of taxes27(486)(27)(100)%513106%
Net income739945212(206)(22)%733NM(1)
Less: net income from continuing operations attributableto noncontrolling interests1303397NM(1)33NM(1)
Less: net income from discontinued operations attributableto noncontrolling interests834(8)(100)%(26)(76)%
Net income available to Genworth Financial, Inc.’s common stockholders$609$904$178$(295)(33)%$726NM(1)
Net income available to Genworth Financial, Inc.’s common stockholders:
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders$609$885$698$(276)(31)%$18727%
Income (loss) from discontinued operations available to Genworth Financial, Inc.’s common stockholders19(520)(19)(100)%539104%
Net income available to Genworth Financial, Inc.’s common stockholders$609$904$178$(295)(33)%$726NM(1)
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and

82

Table of Contents

Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.

Use of non-GAAP measures

Reconciliation of net income (loss) to adjusted operating income (loss)

We use non-GAAP financial measures entitled “adjusted operating income (loss)” and “adjusted operating income (loss) per share.” Adjusted operating income (loss) per share is derived from adjusted operating income (loss). Our chief operating decision maker evaluates segment performance and allocates resources on the basis of adjusted operating income (loss). We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) from continuing operations attributable to noncontrolling interests, net investment gains (losses), gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, initial gains (losses) on insurance block transactions, restructuring costs and infrequent or unusual non-operating items. Initial gains (losses) on insurance block transactions are defined as gains (losses) on the early extinguishment of non-recourse funding obligations, early termination fees for other financing restructuring and/or initial gains (losses) on reinsurance restructuring for certain blocks of business. We exclude net investment gains (losses) and infrequent or unusual non-operating items because we do not consider them to be related to the operating performance of our segments and Corporate and Other activities. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. Gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, initial gains (losses) on insurance block transactions and restructuring costs are also excluded from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating trends. Infrequent or unusual non-operating items are also excluded from adjusted operating income (loss) if, in our opinion, they are not indicative of overall operating trends.

While some of these items may be significant components of net income (loss) in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), including adjusted operating income (loss) per share on a basic and diluted basis, are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses adjusted operating income (loss) as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from adjusted operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Adjusted operating income (loss) and adjusted operating income (loss) per share on a basic and diluted basis are not substitutes for net income (loss) or net income (loss) per share on a basic and diluted basis determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.

Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves.

83

Table of Contents

The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:

(Amounts in millions)202220212020
Net income available to Genworth Financial, Inc.’s common stockholders$609$904$178
Add: net income from continuing operations attributable to noncontrolling interests13033
Add: net income from discontinued operations attributable to noncontrolling interests834
Net income739945212
Less: income (loss) from discontinued operations, net of taxes27(486)
Income from continuing operations739918698
Less: net income from continuing operations attributable to noncontrolling interests13033
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders609885698
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses, net (1)14(324)(503)
Losses on early extinguishment of debt6459
Initial loss from life block transaction92
Expenses related to restructuring2343
Pension plan termination costs8
Taxes on adjustments(6)33103
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$633$765$310
Column 1Column 2
(1)For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(3) million, $(1) million and $(11) million, respectively.

During 2022, we paid a pre-tax make-whole premium of $2 million and wrote off $1 million of bond consent fees and deferred borrowing costs related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in February 2024. Prior to the redemption, we repurchased $130 million principal amount of Genworth Holdings’ senior notes due in February 2024 for a pre-tax loss of $4 million. We also repurchased $13 million principal amount of Genworth Holdings’ senior notes due in 2034 for a pre-tax gain of $1 million during the fourth quarter of 2022. During 2021, we paid a pre-tax make-whole premium of $6 million and $20 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in September 2021 and August 2023, respectively. We also repurchased $146 million principal amount of Genworth Holdings’ senior notes due in September 2021 for a pre-tax loss of $4 million and repurchased $91 million and $118 million principal amount of Genworth Holdings’ senior notes due in 2023 and 2024, respectively, for a pre-tax loss of $15 million. During 2020, we repurchased $84 million principal amount of Genworth Holdings’ senior notes with 2021 maturity dates for a pre-tax gain of $4 million. In January 2020, we paid a pre-tax make-whole expense of $9 million related to the early redemption of Genworth Holdings’ senior notes originally scheduled to mature in June 2020 and Rivermont Life Insurance Company I, our indirect wholly-owned special purpose consolidated captive insurance subsidiary, early redeemed all of its $315 million outstanding non-recourse funding obligations originally due in 2050 resulting in a pre-tax loss of $4 million from the write-off of deferred borrowing costs. These transactions were excluded from adjusted operating income as they relate to gains (losses) on the early extinguishment of debt.

In 2021, we recorded a pre-tax loss of $92 million as a result of ceding certain term life insurance policies as part of a life block transaction.

84

Table of Contents

In 2022, 2021 and 2020, we recorded a pre-tax expense of $2 million, $34 million and $3 million, respectively, related to restructuring costs as we continue to evaluate and appropriately size our organizational needs and expenses.

During 2022, we incurred $8 million of pre-tax pension plan termination costs related to one of our defined benefit pension plans. There were no other infrequent or unusual items excluded from adjusted operating income during the periods presented.

Earnings per share

The following table provides basic and diluted earnings per common share for the years ended December 31:

Increase (decrease) and percentage change
(Amounts in millions, except per share amounts)2022202120202022 vs. 20212021 vs. 2020
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.21$1.75$1.38$(0.54)(31)%$0.3727%
Diluted$1.19$1.72$1.36$(0.53)(31)%$0.3626%
Net income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.21$1.78$0.35$(0.57)(32)%$1.43NM(1)
Diluted$1.19$1.76$0.35$(0.57)(32)%$1.41NM(1)
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share:
Basic$1.26$1.51$0.61$(0.25)(17)%$0.90148%
Diluted$1.24$1.48$0.61$(0.24)(16)%$0.87143%
Weighted-average common shares outstanding:
Basic504.5506.9505.2
Diluted511.0514.7511.6
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including stock options, restricted stock units and other equity-based awards.

85

Table of Contents

The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other activities for the years ended December 31:

Increase (decrease) and
percentage change
(Amounts in millions)2022202120202022 vs. 20212021 vs. 2020
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Enact segment$578$520$381$5811%$13936%
U.S. Life Insurance segment:
Long-term care insurance142445237(303)(68)%20888%
Life insurance(148)(269)(247)12145%(22)(9)%
Fixed annuities729178(19)(21)%1317%
U.S. Life Insurance segment6626768(201)(75)%199NM(1)
Runoff segment375443(17)(31)%1126%
Corporate and Other activities(48)(76)(182)2837%10658%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$633$765$310$(132)(17)%$455147%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

Executive Summary of Consolidated Financial Results

Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.

For a discussion of selected financial information and detailed descriptions of operating performance measures see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”

2022 compared to 2021

Column 1Column 2Column 3Column 4
Net income for the years ended December 31, 2022 and 2021 was $609 million and $904 million, respectively, and adjusted operating income was $633 million and $765 million, respectively.
Column 1Column 2Column 3Column 4
Our Enact segment drove our 2022 consolidated financial results, with $578 million of adjusted operating income, an increase of 11% compared to 2021.
Column 1Column 2Column 3Column 4
The increase was primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the current economic environment.
Column 1Column 2Column 3Column 4
This improvement was partially offset by the minority IPO of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%.
Column 1Column 2Column 3Column 4
The improvement was also partially offset by lower premiums in 2022.
Column 1Column 2Column 3Column 4
Our U.S. Life Insurance segment had adjusted operating income of $66 million and $267 million in 2022 and 2021, respectively.

86

Table of Contents

Column 1Column 2Column 3Column 4
Long-term care insurance:
Column 1Column 2Column 3Column 4
Adjusted operating income in our long-term care insurance business decreased $303 million primarily from higher severity and frequency of new claims, lower net investment income and lower terminations as the pandemic impacts lessened in 2022.
Column 1Column 2Column 3Column 4
The decrease was also attributable to a $49 million less favorable impact in 2022 from in-force rate actions approved and implemented, which included a lower net favorable impact from policyholder benefit reduction elections made in connection with legal settlements, as the implementation of one is materially complete and the implementation of another one began in August 2022.
Column 1Column 2Column 3Column 4
Life insurance:
Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance business decreased $121 million mainly attributable to a favorable unlocking of $34 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2022 compared to an unfavorable unlocking of $70 million in 2021 (see “—Critical Accounting Estimates” for additional information).
Column 1Column 2Column 3Column 4
The decrease was also attributable to lower mortality as the pandemic impacts subsided and lower DAC impairments of $51 million in 2022.
Column 1Column 2Column 3Column 4
These improvements were partially offset by higher lapses in our 20-year term life insurance block written in 2002 entering its post-level premium period in 2022.
Column 1Column 2Column 3Column 4
Fixed annuities:
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuities business decreased $19 million mainly attributable to lower net spreads, partially offset by lower DAC amortization and higher mortality in our single premium immediate annuity products in 2022.
Column 1Column 2Column 3Column 4
Our Runoff segment had adjusted operating income of $37 million and $54 million in 2022 and 2021, respectively.
Column 1Column 2Column 3Column 4
The decrease was predominantly due to the impact from unfavorable equity market performance and higher interest rates on our variable annuity products in 2022.
Column 1Column 2Column 3Column 4
Corporate and Other activities had an adjusted operating loss of $48 million and $76 million in 2022 and 2021, respectively.
Column 1Column 2Column 3Column 4
The decrease in the loss was primarily related to lower interest expense, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

Significant Developments and Strategic Highlights

The periods under review include, among others, the following significant developments and steps taken in the execution of our strategic priorities.

Enact

Column 1Column 2Column 3Column 4
Persistency and loss performance:
Column 1Column 2Column 3Column 4
Enact’s primary persistency rate was 80% for 2022, a meaningful increase compared to 62% for 2021 from rising interest rates and suppressed mortgage refinancing activity in 2022.

87

Table of Contents

Column 1Column 2Column 3Column 4
Higher persistency offset the decline in new insurance written, leading to an increase in insurance in-force of $21.7 billion during 2022.
Column 1Column 2Column 3Column 4
Enact recorded net favorable after-tax reserve adjustments of $212 million during 2022, primarily related to COVID-19 delinquencies curing at levels above original reserve expectations.
Column 1Column 2Column 3Column 4
PMIERs compliance:
Column 1Column 2Column 3Column 4
Enact’s PMIERs sufficiency ratio was 165% or $2,050 million above the published PMIERs requirements as of December 31, 2022.
Column 1Column 2Column 3Column 4
As of December 31, 2022, Enact had estimated available assets of $5,206 million against $3,156 million net required assets under PMIERs compared to available assets of $5,077 million against $3,074 million net required assets as of December 31, 2021 (PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE restrictions imposed on Enact Holdings).
Column 1Column 2Column 3Column 4
As of December 31, 2022 and 2021, Enact’s PMIERs required assets benefited by $132 million and $390 million, respectively, from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans.
Column 1Column 2Column 3Column 4
Given Genworth’s strengthened financial position, including achieving its strategic priority to reduce its outstanding public debt at Genworth Holdings to approximately $1.0 billion, we believe Genworth satisfied two consecutive quarters of financial metric conditions during the fourth quarter of 2022 related to the GSE Restrictions imposed on Enact. We expect the GSE Restrictions to be lifted in the first quarter of 2023, subject to GSE review and confirmation.

For additional information related to PMIERs, see “Item 1—Business—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

Column 1Column 2Column 3Column 4
Dividends and other return of capital:
Column 1Column 2Column 3Column 4
On April 26, 2022, Enact Holdings’ board of directors approved the initiation of a dividend program under which it intends to pay a quarterly cash dividend, subject to a quarterly review by its board of directors.
Column 1Column 2Column 3Column 4
Pursuant to the program, Enact Holdings paid quarterly dividends beginning in the second quarter of 2022, and Genworth Holdings received $57 million during 2022 as the majority shareholder.
Column 1Column 2Column 3Column 4
In the fourth quarter of 2022, Enact Holdings paid a special dividend and Genworth Holdings received $148 million as the majority shareholder.
Column 1Column 2Column 3Column 4
On November 1, 2022, Enact Holdings also announced the approval by its board of directors of a share repurchase program under which Enact Holdings may repurchase up to $75 million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022.
Column 1Column 2Column 3Column 4
Liquidity and financial flexibility:
Column 1Column 2Column 3Column 4
On June 30, 2022, Enact Holdings entered into a $200 million unsecured revolving credit facility that remained undrawn as of December 31, 2022.

U.S. Life Insurance

Column 1Column 2Column 3Column 4
Long-term care insurance multi-year in-force rate action plan:
Column 1Column 2Column 3Column 4
We estimate that the cumulative economic benefit of our long-term care insurance multi-year in-force rate action plan through 2022 was approximately $23.5 billion, on a net present value basis, of the total expected amount required of $30.3 billion as of December 31, 2022.

88

Table of Contents

Column 1Column 2Column 3Column 4
We received 139 filing approvals from 35 states during 2022, representing a weighted-average increase of 48% on approximately $1,143 million in annualized in-force premiums, or approximately $549 million of incremental annual premiums. Of that aggregate amount, we are awaiting the final disposition of a small number of the approvals as we work through implementation mechanics.
Column 1Column 2Column 3Column 4
We also submitted 139 new filings in 37 states during 2022 on approximately $1,226 million in annualized in-force premiums.
Column 1Column 2Column 3Column 4
Profits followed by losses in our long-term care insurance business:
Column 1Column 2Column 3Column 4
Future projections in our long-term care insurance block, excluding the acquired block, indicate we have projected profits in earlier periods followed by projected losses in later periods.
Column 1Column 2Column 3Column 4
As a result of this pattern of projected profits followed by projected losses, we ratably accrue additional future policy benefit reserves over the profitable periods by the amounts necessary to offset estimated losses during the periods that follow.
Column 1Column 2Column 3Column 4
As of December 31, 2022 and 2021, the total amount accrued for profits followed by losses was $1.7 billion and $1.3 billion, respectively.
Column 1Column 2Column 3Column 4
Completion of annual long-term care insurance assumption review:
Column 1Column 2Column 3Column 4
In the fourth quarter of 2022, we completed a review of our assumptions and methodologies of our claim reserves and future policy benefits for our long-term care insurance business and completed loss recognition testing.
Column 1Column 2Column 3Column 4
We made no significant changes to our existing claim reserves, as experience in the aggregate was in line with expectations.
Column 1Column 2Column 3Column 4
In aggregate, the 2022 margins for our long-term care insurance business remained in the same range as 2021 of approximately $0.5 billion to $1.0 billion.
Column 1Column 2Column 3Column 4
Completion of annual life insurance assumption review:
Column 1Column 2Column 3Column 4
We also completed a review of our assumptions and methodologies of our life insurance business and completed loss recognition testing in the fourth quarter of 2022.
Column 1Column 2Column 3Column 4
The loss recognition testing margin for our term life insurance products remained positive at over $1.0 billion in 2022.
Column 1Column 2Column 3Column 4
As part of our review in the fourth quarter of 2022, we recorded a $34 million after-tax benefit to net income in our universal and term universal life insurance products primarily related to higher interest rates.

For additional information see “—Critical Accounting Estimates.”

Liquidity and Capital Resources

Column 1Column 2Column 3Column 4
Execution of strategic plan to reduce debt maturities:
Column 1Column 2Column 3Column 4
On September 21, 2022, Genworth Holdings early redeemed the remaining $152 million principal balance of its 4.80% senior notes due in February 2024. This redemption resulted in the achievement of Genworth’s strategic goal of reducing debt at Genworth Holdings to approximately $1.0 billion.
Column 1Column 2Column 3Column 4
In the fourth quarter of 2022, Genworth Holdings repurchased $13 million principal amount of its senior notes due in June 2034.
Column 1Column 2Column 3Column 4
As of December 31, 2022, Genworth Holdings had outstanding principal of $887 million of long-term debt, with no debt maturities until June 2034.

89

Table of Contents

Column 1Column 2Column 3Column 4
During the first half of 2022 and prior to the early redemption, Genworth Holdings repurchased $130 million of its senior notes due in February 2024.

See note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information on our long-term borrowings.

Column 1Column 2Column 3Column 4
Genworth Financial share repurchase program:
Column 1Column 2Column 3Column 4
On May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock.
Column 1Column 2Column 3Column 4
During 2022, Genworth Financial repurchased 16,173,196 shares of its common stock at an average price of $3.94 per share for a total cash outlay of $64 million.
Column 1Column 2Column 3Column 4
Genworth Financial also repurchased 5,912,297 shares from February 9, 2023 through February 24, 2023 of its common stock at an average price of $6.08 per share for a total cost of $36 million, leaving approximately $250 million that may yet be purchased under the share repurchase program.

Results of Operations and Selected Financial and Operating Performance Measures by Segment

Our chief operating decision maker evaluates segment performance and allocates resources on the basis of adjusted operating income (loss).

Management’s discussion and analysis by segment contains selected operating performance measures including “sales” and “insurance in-force” or “risk in-force” which are commonly used in the insurance industry as measures of operating performance.

Management regularly monitors and reports sales metrics as a measure of volume of new business generated in a period. Sales refer to new insurance written for mortgage insurance products included in our Enact segment. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of insurance policies during a specified period, rather than a measure of revenues or profitability during that period.

Management regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.

Management regularly monitors and reports a loss ratio for our businesses. For our mortgage insurance businesses included in our Enact segment, the loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. For our long-term care insurance business included in our U.S. Life Insurance segment, the loss ratio is the ratio of benefits and other changes in reserves less tabular interest on reserves less loss adjustment expenses to net earned premiums. We consider the loss ratio to be a measure of underwriting performance in these businesses and helps to enhance the understanding of the operating performance of our businesses.

Management also regularly monitors and reports adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions in the long-term care insurance

90

Table of Contents

business included in our U.S. Life Insurance segment. In-force rate actions include premium rate increases and associated benefit reductions implemented since 2012, which are presented net of estimated premium taxes, commissions, and other expenses on an after-tax basis. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual historical results, including but not limited to, a uniform rate of coinsurance and premium taxes in addition to consistent policyholder behavior over time. Actual policyholder behavior may differ significantly from these assumptions. In addition, estimates exclude reserve updates resulting from profits followed by losses and reserve changes for group products. Management considers adjusted operating income attributable to in-force rate actions to be a measure of our operating performance because it helps bring older generation long-term care insurance blocks closer to a break-even point over time and helps bring the loss ratios on newer long-term care insurance blocks back towards their original pricing.

These operating performance measures enable us to compare our operating performance across periods without regard to revenues or profitability related to policies or contracts sold in prior periods or from investments or other sources.

Enact segment

Trends and conditions

Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included herein “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.

Mortgage origination activity declined throughout 2022 in response to rising mortgage rates. If interest rates remain high, the refinance market is likely to remain depressed. Housing affordability was challenged in 2022 due to increasing interest rates, low inventory and elevated home prices, modestly offset by rising median family income, according to the National Association of Realtors Housing Affordability Index. Annual home price appreciation slowed throughout 2022, and home prices declined in the second half of the year, according to the FHFA Monthly Purchase-Only House Price Index.

The unemployment rate decreased to 3.5% in December 2022, compared to 3.9% in December 2021, following a decline from its peak of 14.8% in April 2020, bringing unemployment in line with the pre-pandemic level of 3.5% in February 2020. As of December 31, 2022, the number of unemployed Americans was under 6 million, and the number of long term unemployed over 26 weeks was approximately one million. Both of these metrics remain relatively in line with February 2020 levels.

For mortgages insured by the federal government (including those purchased by Fannie Mae and Freddie Mac), forbearance allows borrowers impacted by COVID-19 to temporarily suspend mortgage payments up to 18 months subject to certain limits. Currently, the GSEs do not have a deadline for requesting an initial forbearance. Federal laws and regulations continue to require servicers to discuss loss mitigation options with borrowers before proceeding with foreclosures. These requirements could further extend the foreclosure timeline, which could negatively impact the severity of loss on loans that go to claim.

Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2022, approximately 1.5% or 14,270 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 36% were reported as delinquent compared with approximately 2% or 21,899 of its active primary policies reported in forbearance with

91

Table of Contents

approximately 47% reported as delinquent as of December 31, 2021. Natural disasters, such as hurricanes, often lead to temporary increases in delinquencies in forbearance. While Enact experienced a small increase in delinquencies in the fourth quarter of 2022 related to the recent hurricane impacting the southeastern United States, it did not have a material impact on loss reserves as of December 31, 2022. Enact will continue to monitor the affected areas and support measures enacted by the GSEs, including allowing forbearance, restricting foreclosure actions and providing other forms of mortgage relief for those who experienced property damage.

Total delinquencies decreased during 2022 compared to 2021 as a result of cures outpacing new delinquencies. The 2022 new delinquency rate of 3.8%, while slightly higher than the 2021 new delinquency rate of 3.5%, was in line with Enact’s pre-pandemic levels. The full impact of COVID-19 and its adverse economic effects on Enact’s future business results are difficult to predict. Given the maximum length of forbearance plans, the resolution of a delinquency in a plan may not be known for several quarters. Enact continues to monitor regulatory and government actions and the resolution of forbearance delinquencies. While the associated risks have moderated and delinquencies have declined, it is possible that COVID-19 related forbearance programs could have an adverse impact on Enact’s future results of operations and financial condition.

Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products. On February 25, 2022, the FHFA finalized the rule for the Enterprise Capital Framework, which included technical corrections to its December 17, 2020 rule. Higher GSE capital requirements could lead to increased costs to borrowers of GSE loans, which in turn could shift the market away from the GSEs to the FHA or lender portfolios. Such a shift could result in a smaller market for private mortgage insurance.

In January 2022, the FHFA introduced new upfront fees charged to borrowers for some high-balance and second home loans sold to Fannie Mae and Freddie Mac, which became effective April 1, 2022. Upfront fees for high-balance loans increased between 0.25% and 0.75%, tiered by loan-to-value ratio. For second home loans, the upfront fees increased between 1.125% and 3.875%, also tiered by loan-to-value ratio. To date, Enact has not experienced a significant impact to its business or results of operations as a result of this new pricing framework.

On October 24, 2022, the FHFA announced targeted changes to the GSEs’ guarantee fee pricing by eliminating upfront fees for certain first-time home buyers with income at or below area median income and for certain GSE affordable mortgage products, while implementing targeted increases to the upfront fees for most cash-out refinance loans. The fee reductions went into effect in the fourth quarter of 2022 while the new fees on cash-out refinance loans began February 1, 2023. Enact expects these price changes to have a net positive impact to the private mortgage insurance market.

The FHFA also announced in October 2022 its validation and approval of certain credit score models for use by the GSEs and changed the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores requires lenders to deliver both credit scores for each loan sold to the GSEs. There is currently no implementation deadline, and this is expected to be a multiple year process that will require system and process updates.

In January 2023, the FHFA announced additional updates to its upfront fee structure and pricing matrix. The changes impact purchase and rate-term refinance loans with pricing grids to be broken out by loan purpose and recalibrated to new credit score and loan-to-value ratio categories, along with associated loan attributes. The new pricing matrix also includes new upfront fees for loans with debt-to-income ratios greater than 40%. These changes will go into effect in May 2023. Enact is currently evaluating the impact of these changes but does not expect a significant impact to the private mortgage insurance market.

92

Table of Contents

In February 2023, the Department of Housing and Urban Development announced a 30 basis point reduction of the annual insurance premium charged to borrowers with FHA-insured mortgages in order to reduce the cost of borrowing for eligible lower and middle class homebuyers. This price reduction is expected to have a negative impact on the U.S. private mortgage insurance market but will be partially offset by the effects of the recent FHFA pricing changes referenced above. Enact does not expect the net impact to be material.

The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite enabling it to write new business at returns it views as attractive.

New insurance written of $66.5 billion in 2022 decreased 31% compared to 2021 primarily due to a smaller estimated private mortgage insurance market. The decrease in the estimated private mortgage insurance market was largely driven by lower purchase and refinancing originations due to rising interest rates.

Enact’s primary persistency rate increased to 80% for the year ended December 31, 2022 compared to 62% for the year ended December 31, 2021. The increase in persistency was primarily driven by a decline in the percentage of in-force policies with mortgage rates above current interest rates and offset the decline in new insurance written in 2022, leading to an increase in insurance in-force of $21.7 billion during 2022. Higher persistency impacted business performance trends in several ways, including but not limited to, slowing the recognition of earned premiums due to lower single premium policy cancellations, slowing the amortization of existing reinsurance transactions and the corresponding reduction of PMIERs capital credit, and shifting the concentration of Enact’s primary insurance in-force by policy year. As of December 31, 2022, Enact’s primary insurance in-force had approximately 58% concentration in 2022 and 2021 book years compared to 71% primary insurance in-force concentration in 2021 and 2020 book years as of December 31, 2021.

Net earned premiums decreased in 2022 compared to 2021 primarily from the lapse of older, higher priced policies and from lower single premium policy cancellations, partially offset by insurance in-force growth in 2022. The total number of delinquent loans has declined from the COVID-19 peak in the second quarter of 2020 as borrowers continued to exit forbearance plans and new forbearances declined. During this time, and consistent with prior years, servicers continued the practice of remitting premiums during the early stages of default and Enact refunds the post-delinquent premiums to the insured party if the delinquent loan goes to claim. Enact records a liability and a reduction to net earned premiums for the post-delinquent premiums it expects to refund. The post-delinquent premium liability recorded since the beginning of COVID-19 in the second quarter of 2020 through December 31, 2022 was not significant to the change in earned premiums for those periods as a result of the high concentration of new delinquencies being subject to a servicer reported forbearance plan and the lower estimated claim rate for these loans.

Enact’s loss ratio was (10)% for the year ended December 31, 2022, compared to 13% for the year ended December 31, 2021. The decrease was largely from net favorable reserve adjustments of $268 million in 2022, primarily related to favorable cure performance on COVID-19 delinquencies from 2020 and 2021. During the peak of COVID-19, Enact experienced elevated new delinquencies subject to forbearance plans. Those delinquencies have been curing at levels above Enact’s reserve expectations, which led to releases of $314 million of reserves in 2022. These reserve releases were partially offset by reserve strengthening on certain 2022 delinquencies. Due to uncertainty in the current economic environment, Enact increased the expected claim rate on new delinquencies during 2022. New delinquencies in the fourth quarter of 2022 were recorded at the higher expected claim rate and reserves on delinquencies from prior quarters in 2022 were strengthened by $46 million. In 2021, Enact decreased reserves by $22 million primarily related to positive frequency and severity development on pre-COVID-19 delinquencies.

93

Table of Contents

Enact’s loss reserves continue to be impacted by COVID-19 and remain subject to uncertainty. Borrowers who have experienced a financial hardship including, but not limited to, the loss of income due to the closing of a business or the loss of a job continue to take advantage of available loss mitigation options, including forbearance programs, payment deferral options and other modifications. Loss reserves recorded on these delinquencies require a high degree of estimation due to the level of uncertainty regarding whether delinquencies in forbearance will ultimately cure or result in claim payments, as well as the timing and severity of those payments. The severity of loss on loans that do go to claim may be negatively impacted by the extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of the recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.

New primary delinquencies in 2022 increased compared to 2021. New primary delinquencies of 35,996 contributed $171 million of loss expense in 2022, while Enact incurred $144 million of losses from 32,624 new primary delinquencies in 2021. In determining the loss expense estimate, considerations were given to forbearance and non-forbearance delinquencies, recent cure and claim experience and the prevailing and prospective economic conditions. Approximately 21% of Enact’s primary new delinquencies in 2022 were subject to a forbearance plan as compared to 42% in 2021.

EMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 12.9:1 as of December 31, 2022 compared with a risk-to-capital ratio of 12.3:1 as of December 31, 2021. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.

Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. Since 2020, the GSEs have issued several amendments to PMIERs, which implemented both permanent and temporary revisions to PMIERs. Many of the provisions are no longer applicable, but for loans that became non-performing due to a COVID-19 hardship, PMIERs was temporarily amended with respect to each non-performing loan that (i) had an initial missed monthly payment occurring on or after March 1, 2020 and prior to April 1, 2021 or (ii) is subject to a forbearance plan granted in response to a financial hardship related to COVID-19, the terms of which are materially consistent with terms of forbearance plans offered by the GSEs. The risk-based required asset amount factor for the non-performing loan is the greater of (a) the applicable risk-based required asset amount factor for a performing loan were it not delinquent, and (b) the product of a 0.30 multiplier and the applicable risk-based required asset amount factor for a non-performing loan. In the case of (i) above, absent the loan being subject to a forbearance plan described in (ii) above, the 0.30 multiplier was applicable for no longer than three calendar months beginning with the month in which the loan became a non-performing loan due to having missed two monthly payments. Loans subject to a forbearance plan described in (ii) above include those that are either in a repayment plan or loan modification trial period following the forbearance plan unless reported to the approved insurer that the loan is no longer in such forbearance plan, repayment plan, or loan modification trial period. The PMIERs amendment dated June 30, 2021 further allows loans that enter a forbearance plan due to a COVID-19 hardship on or after April 1, 2021 to remain eligible for extended application of the reduced PMIERs capital factor for as long as the loan remains in forbearance. In addition, the PMIERs amendments made permanent revisions to the risk-based required asset amount factor for non-performing loans for properties located in future FEMA Declared Major Disaster Areas eligible for individual assistance.

94

Table of Contents

In addition, in September 2020, certain GSE Restrictions were imposed with respect to capital on Enact, which will remain in effect until the collective GSE Conditions are met. For additional details related to PMIERs, the PMIERs amendments and the GSE Conditions and Restrictions, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”

As of December 31, 2022, Enact had estimated available assets of $5,206 million against $3,156 million net required assets under PMIERs compared to available assets of $5,077 million against $3,074 million net required assets as of December 31, 2021. The sufficiency ratio as of December 31, 2022 and 2021 was 165%, or $2,050 million and $2,003 million, respectively, above the published PMIERS requirements. PMIERs sufficiency is based on the published requirements applicable to private mortgage insurers and does not give effect to the GSE Restrictions imposed on Enact. Enact’s PMIERs required assets as of December 31, 2022 and 2021 benefited from the application of a 0.30 multiplier applied to the risk-based required asset amount factor for certain non-performing loans. The application of the 0.30 multiplier to all eligible delinquencies provided $132 million and $390 million of benefit to Enact’s PMIERs required assets as of December 31, 2022 and 2021, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier.

Credit risk transfer transactions provided an aggregate of approximately $1,578 million of PMIERs capital credit as of December 31, 2022. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.

On April 26, 2022, Enact Holdings’ board of directors approved the initiation of a quarterly dividend program. Pursuant to the program, Enact Holdings paid quarterly dividends beginning in the second quarter of 2022, and Genworth Holdings received $57 million in 2022 as the majority shareholder. Enact Holdings also paid a special dividend in the fourth quarter of 2022, and Genworth Holdings received $148 million. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition, in November 2022, Enact Holdings announced approval by its board of directors of a share repurchase program under which it may repurchase up to $75 million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022.

EMICO completed distributions to Enact Holdings in April 2022 and October 2022, the proceeds of which were used to support Enact Holdings’ cash dividends. Enact Holdings intends to use future EMICO distributions to fund the quarterly dividend as well as to bolster its financial flexibility and potentially return additional capital to shareholders. Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings, as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, including: supporting its existing policyholders; growing its mortgage insurance business; funding attractive new business opportunities; and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.

95

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Enact segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Premiums$940$975$971$(35)(4)%
Net investment income1551411331410%
Net investment gains (losses)(2)(2)(4)%
Policy fees and other income246(2)(50)%
Total revenues1,0951,1181,106(23)(2)%
Benefits and expenses:
Benefits and other changes in policy reserves(94)125381(219)(175)%
Acquisition and operating expenses, net of deferrals227230206(3)(1)%
Amortization of deferred acquisition costs and intangibles121521(3)(20)%
Interest expense52511812%
Total benefits and expenses197421626(224)(53)%
Income from continuing operations before income taxes89869748020129%
Provision for income taxes1941481024631%
Income from continuing operations70454937815528%
Less: net income from continuing operations attributable to
noncontrolling interests1303397NM(1)
Income from continuing operations available to Genworth
Financial, Inc.’s common stockholders5745163785811%
Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders:
Net investment (gains) losses224%
Expenses related to restructuring33%
Taxes on adjustments(1)(1)(1)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$578$520$381$5811%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

2022 compared to 2021

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income increased primarily attributable to lower losses largely driven by net favorable reserve adjustments of $212 million, consisting of reserve releases of $248 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening of $36 million related to 2022 delinquencies given uncertainty in the current economic environment. This improvement was partially offset by the minority IPO of Enact Holdings that closed in September 2021, which reduced Genworth Financial’s ownership percentage to 81.6%, and lower premiums in 2022.

96

Table of Contents

Revenues

Premiums decreased mainly driven by the lapse of older, higher priced policies and lower single premium policy cancellations, partially offset by higher insurance in-force in 2022 driven by increased persistency.

Net investment income increased primarily due to higher investment yields and higher average invested assets, partially offset by lower income from bond calls in 2022.

Benefits and expenses

Benefits and other changes in policy reserves decreased largely from net favorable reserve adjustments of $268 million, partially offset by higher new delinquencies in 2022. During 2022, Enact released $314 million of reserves primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening on certain 2022 delinquencies. Due to uncertainty in the current economic environment, Enact increased the expected claim rate on new delinquencies during 2022. New delinquencies in the fourth quarter of 2022 were recorded at the higher expected claim rate and reserves on delinquencies from prior quarters in 2022 were strengthened by $46 million. In 2021, Enact decreased reserves by $22 million primarily related to positive frequency and severity development on pre-COVID-19 delinquencies.

Acquisition and operating expenses, net of deferrals, decreased primarily attributable to expenses associated with strategic transaction preparations in 2021 that did not recur.

Amortization of deferred acquisition costs and intangibles decreased primarily due to lower DAC amortization largely from higher persistency in 2022 driven by rising interest rates.

Provision for income taxes. The effective tax rate was 21.6% and 21.3% for the years ended December 31, 2022 and 2021, respectively, consistent with the U.S. corporate federal income tax rate.

Net income from continuing operations attributable to noncontrolling interests. The increase relates to the minority IPO of Enact Holdings on September 16, 2021, which reduced Genworth Financial’s ownership percentage to 81.6%.

Enact selected operating performance measures

The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Primary insurance in-force(1)$248,262$226,514$207,947$21,74810%
Risk in-force:
Primary$62,791$56,881$52,475$5,91010%
Pool79105146(26)(25)%
Total risk in-force$62,870$56,986$52,621$5,88410%
New insurance written$66,485$97,004$99,871$(30,519)(31)%
Column 1Column 2
(1)Primary insurance in-force represents the aggregate unpaid principal balance for loans Enact insures.

97

Table of Contents

2022 compared to 2021

Primary insurance in-force and risk in-force

Primary insurance in-force increased largely from new insurance written. In addition, lower lapses and cancellations drove higher primary persistency, largely as a result of a decline in refinancing activity due to rising interest rates in 2022. The primary persistency rate was 80% and 62% for the years ended December 31, 2022 and 2021, respectively. Total risk in-force increased largely from higher primary insurance in-force.

New insurance written

New insurance written decreased principally due to a smaller estimated private mortgage insurance market in 2022, which was primarily driven by a decline in both purchase and refinancing originations due to rising interest rates.

Loss and expense ratios

The following table sets forth the loss and expense ratios for Enact for the dates indicated:

Years ended December 31,Increase (decrease)
2022202120202022 vs. 2021
Loss ratio(10)%13%39%(23)%
Expense ratio25%25%23%%

The loss ratio is the ratio of benefits and other changes in policy reserves to net earned premiums. The expense ratio is the ratio of general expenses to net earned premiums. In Enact, general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles.

2022 compared to 2021

The loss ratio decreased largely from net favorable reserve adjustments of $268 million, as discussed above, partially offset by higher new delinquencies in 2022. Enact decreased reserves by $22 million in 2021 primarily related to positive frequency and severity development on pre-COVID-19 delinquencies.

The expense ratio remained flat as lower premiums were offset by expenses associated with strategic transaction preparations in 2021 that did not recur.

98

Table of Contents

Mortgage insurance loan portfolio

The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:

(Amounts in millions)202220212020
Primary insurance in-force by loan-to-value ratio at origination:
95.01% and above$39,509$35,455$34,520
90.01% to 95.00%103,61895,14992,689
85.01% to 90.00%72,13264,54956,341
85.00% and below33,00331,36124,397
Total$248,262$226,514$207,947
Primary risk in-force by loan-to-value ratio at origination:
95.01% and above$11,136$9,907$9,279
90.01% to 95.00%30,07927,60826,774
85.01% to 90.00%17,62115,64413,562
85.00% and below3,9553,7222,860
Total$62,791$56,881$52,475
Primary insurance in-force by credit quality at origination:
Over 760$102,467$89,982$78,488
740—75940,09735,87433,635
720—73934,91631,73030,058
700—71928,86727,35925,870
680—69921,55421,27020,140
660—679(1)10,92610,5499,819
640—6596,0956,1245,935
620—6392,6302,7832,902
6207108431,100
Total$248,262$226,514$207,947
Primary risk in-force by credit quality at origination:
Over 760$25,807$22,489$19,691
740—75910,1549,0098,497
720—7398,9318,0557,673
700—7197,3176,9076,579
680—6995,4285,3345,100
660—679(1)2,7672,6382,442
640—6591,5401,5301,472
620—639665702737
620182217284
Total$62,791$56,881$52,475
Column 1Column 2
(1)Loans with unknown FICO scores are included in the 660-679 category.

The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 743 as of December 31, 2022.

99

Table of Contents

Delinquent loans and claims

Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:

202220212020
Primary insurance:
Insured loans in-force960,306937,350924,624
Delinquent loans19,94324,82044,904
Percentage of delinquent loans (delinquency rate)2.08%2.65%4.86%

The delinquency rate as of December 31, 2022 decreased compared to December 31, 2021 and 2020 primarily from a decline in total delinquencies as cures outpaced new delinquencies.

The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31:

2022
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less8,920$69$50914%
4 - 11 payments6,46616639043%
12 payments or more4,55724424898%
Total19,943$479$1,14742%
2021
(Dollar amounts in millions)DelinquenciesDirect primary case reserves(1)Risk in-forceReserves as % of risk in-force
Payments in default:
3 payments or less6,586$35$34010%
4 - 11 payments7,36011142626%
12 payments or more10,87446064372%
Total24,820$606$1,40943%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, incurred but not reported (“IBNR”) and reinsurance reserves.

Total reserves as a percentage of risk in-force as of December 31, 2022 remained relatively flat as both delinquent risk in-force and reserves decreased. Delinquent risk in-force decreased mainly from lower total delinquencies as cures outpaced new delinquencies in 2022, while reserves decreased largely from favorable

100

Table of Contents

reserve adjustments related to COVID-19 delinquencies from 2020 and 2021, partially offset by new delinquencies in 2022.

The number of loans that are delinquent for 12 months or more was elevated as of December 31, 2021 due in large part to borrowers in forbearance plans driven by COVID-19 and decreased in 2022 due to cure activity. Enact’s current reserve estimate assumes that remaining COVID-19 delinquencies will have a higher likelihood of going to claim given the uncertainty around lack of progression through the foreclosure process. While Enact has seen significant cure activity in aged delinquencies, forbearance options continue to exist, so Enact could continue to experience elevated delinquencies in this aged category. Resolution of a delinquency in a forbearance plan, whether it ultimately results in a cure or a claim, is difficult to estimate and may not be known for several quarters, if not longer.

Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.

Percent of primary risk in-force as of December 31, 2022Percent of direct primary case reserves as of December 31, 2022(1)Delinquency rate as of December 31,
202220212020
By State:
California12%10%2.09%3.17%6.20%
Texas8%7%2.12%2.89%5.82%
Florida(2)8%8%2.54%2.97%6.92%
New York(2)5%13%2.95%3.80%6.92%
Illinois(2)5%6%2.54%3.09%5.21%
Arizona4%2%1.78%2.31%4.54%
Michigan4%3%1.79%1.87%2.93%
North Carolina3%3%1.59%2.18%3.84%
Georgia3%3%2.23%2.94%5.89%
Washington3%3%1.92%2.98%5.37%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.
Column 1Column 2
(2)Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed.

101

Table of Contents

Percent of primary risk in-force as of December 31, 2022Percent of direct primary case reserves as of December 31, 2022(1)Delinquency rate as of December 31,
202220212020
By MSA or MD:
Chicago-Naperville, IL MD3%5%2.84%3.68%6.36%
Phoenix, AZ MSA3%2%1.83%2.36%4.63%
New York, NY MD3%8%3.75%5.32%10.25%
Atlanta, GA MSA2%3%2.42%3.28%6.68%
Washington-Arlington, DC MD2%2%1.85%2.96%6.09%
Houston, TX MSA2%3%2.60%3.61%7.59%
Riverside-San Bernardino, CA MSA2%2%2.89%3.42%7.08%
Los Angeles-Long Beach, CA MD2%2%2.18%3.95%7.57%
Dallas, TX MD2%1%1.86%2.31%5.10%
Denver-Aurora-Lakewood, CO MSA2%1%1.12%1.66%3.77%
Column 1Column 2
(1)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.

The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, weighted average mortgage interest rate and delinquency rate as of December 31, 2022:

(Amounts in millions)Weighted average rate(1)Percent of direct primary case reserves(2)Primary insurance in-forcePercent of totalPrimary risk in-forcePercent of totalDelinquency rate
Policy Year
2008 and prior5.70%26%$6,5963%$1,6993%9.61%
2009 to 20144.45%42,113156015.01%
20154.20%32,912178113.61%
20163.91%66,29621,68133.17%
20174.28%76,49531,70833.78%
20184.81%96,83931,73634.63%
20194.24%1116,35274,14372.71%
20203.26%1755,3582214,158221.47%
20213.10%1481,7243320,418321.20%
20224.88%363,5772515,907250.54%
Total portfolio3.84%100%$248,262100%$62,791100%2.08%
Column 1Column 2
(1)Average annual mortgage interest rate weighted by insurance in-force.
Column 1Column 2
(2)Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves.

102

Table of Contents

Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The largest portion of reserves has shifted to newer book years as a result of COVID-19 given their significant representation of risk in-force. As of December 31, 2022, Enact’s 2015 and newer policy years represented approximately 96% of primary risk in-force and 70% of total direct primary case reserves.

The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 94%, 103% and 106% for the years ended December 31, 2022, 2021 and 2020, respectively. The average claim severity for the year ended December 31, 2022 was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans.

U.S. Life Insurance segment

Trends and conditions

Results of our U.S. life insurance businesses depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves. Many factors can affect the results of our U.S. life insurance businesses. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our U.S. life insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our DAC amortization, reserve levels, results of operations and financial condition.

Our liability for policy and contract claims is reviewed quarterly and we completed a detailed review of our claim reserve assumptions and methodologies for our long-term care insurance business in the fourth quarter of 2022 as discussed further below. In the fourth quarter of 2022, we performed assumption reviews for our U.S. life insurance products, including our long-term care and life insurance products, and completed our loss recognition testing as discussed below. For our 2022 assumption updates, we generally did not include data after 2019 in setting any long-term assumptions, as we do not yet have sufficient information around longer term effects of the pandemic, which is consistent with the approach for our 2021 assumptions. Our review of assumptions, as part of our testing in the fourth quarter of 2022, included assumptions regarding expected claim incidence and terminations, expenses, benefit utilization, mortality, persistency, interest rates and in-force rate actions, among other assumptions. In addition, we performed cash flow testing separately for each of our U.S. life insurance companies on a statutory accounting basis in the fourth quarter of 2022.

Our U.S. life insurance subsidiaries are subject to the NAIC’s RBC standards and other minimum statutory capital and surplus requirements. As of December 31, 2022, the RBC of each of our U.S. life insurance subsidiaries exceeded the level of RBC that would require any of them to take or become subject to any corrective action in their respective domiciliary state, or company action level RBC ratio. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 291% and 289% as of December 31, 2022 and 2021, respectively. The slight increase was driven by earnings in our long-term care insurance business mainly from premium rate increases and benefit reductions, including policyholder benefit reduction elections

103

Table of Contents

made in connection with legal settlements, that were mostly offset by high mortality in our life insurance products and unfavorable equity market performance in our variable annuity products.

We continue to face challenges in our principal life insurance subsidiaries, particularly those subsidiaries that rely heavily on long-term care insurance in-force rate actions as a source of earnings and capital. We may see variability in statutory results and a decline in the company action level RBC ratios of these subsidiaries given the time lag between the approval of in-force rate actions versus when the benefits from the in-force rate actions (including increased premiums and associated benefit reductions) are fully realized in our financial results. Additionally, the company action level RBC ratio of our U.S. life insurance subsidiaries would be negatively impacted by future increases in our statutory reserves, including results of life mortality, cash flow testing and assumption reviews, particularly in our long-term care and life insurance products. Future declines in the company action level RBC ratio of our life insurance subsidiaries could result in heightened supervision and regulatory action.

Results of our U.S. life insurance businesses are also impacted by interest rates. Prior to the recent rise in interest rates during 2022, historic low interest rates put pressure on the profitability and returns of our U.S. life insurance businesses as higher yielding investments matured and were replaced with lower-yielding investments. We have sought to manage the impact of low interest rates through asset-liability management, investment in alternative assets, including limited partnerships, as well as interest rate hedging strategies for a portion of our long-term care insurance product cash flows. Additionally, certain products have implicit and explicit rate guarantees or optionality that are significantly impacted by changes in interest rates. During periods of increasing market interest rates, we may increase crediting rates on in-force universal life insurance and fixed annuity products to remain competitive in the marketplace. In addition, rapidly rising interest rates may cause increased unrealized losses on our investment portfolios, increased policy surrenders, withdrawals from life insurance policies and annuity contracts and requests for policy loans, as policyholders and contractholders shift assets into higher yielding investments. Increases in crediting rates, as well as surrenders and withdrawals, could have an adverse effect on our financial condition and results of operations, including the requirement to liquidate fixed-income investments in an unrealized loss position to satisfy surrenders or withdrawals. For a further discussion of the impact of interest rates on our U.S. life insurance businesses, see “Item 7A—Quantitative and Qualitative Disclosures About Market Risk.”

In recent years, our U.S. life insurance businesses have been impacted by COVID-19 as a result of elevated mortality. Our long-term care insurance operating results were favorably impacted by higher mortality in 2021 and 2020. This trend continued into 2022 albeit to a lesser extent, and we have seen mortality levels return to pre-pandemic levels in the latter half of 2022 in our long-term care insurance business. Conversely, higher mortality rates had unfavorable impacts in our life insurance products; however, we have seen lower mortality since the first quarter of 2022. We have also observed minimal impact from COVID-19 in our fixed annuity products. While the ongoing impact of COVID-19 is very difficult to predict, the related outcomes and impact on the U.S. life insurance business currently depend on the after-effects indirectly caused by the pandemic, including supply chain shortages and high inflation, and the shape of the economic recovery. For sensitivities related to lapses and mortality on our U.S. life insurance products, see “—Critical Accounting Estimates.” We will continue to monitor COVID-19 associated impacts and evaluate all of our assumptions that may need updating as a result of longer-term trends related to the pandemic.

Long-term care insurance

The long-term profitability of our long-term care insurance business depends upon how our actual experience compares with our valuation assumptions, including but not limited to morbidity, mortality and persistency. If any of our assumptions prove to be inaccurate, our reserves may be inadequate, which in the past has had, and may in the future have, a material adverse effect on our results of operations, financial condition and business. Results of our long-term care insurance business are also influenced by our ability to achieve in-force rate actions, improve investment yields and manage expenses and reinsurance, among other factors. Changes in

104

Table of Contents

laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, could also impact our long-term care insurance business either positively or negatively.

In the fourth quarter of 2022, we completed loss recognition and cash flow testing and reviewed key assumptions for future policy benefits, or active life reserves, for our long-term care insurance business, including assumptions regarding expected claim incidence and terminations, expenses, benefit utilization, interest rates and in-force rate actions, among other assumptions. As of December 31, 2022, our loss recognition testing margin for our long-term care insurance business, excluding the acquired block, was positive but slightly lower than the 2021 level. We continue to test our acquired block of long-term care insurance separately. In 2022, our loss recognition testing margin for the acquired block was positive and slightly higher than the 2021 level. All key margin testing assumptions were reviewed and updated where appropriate. We refined several assumptions, including reducing our lapse assumption in light of favorable experience from our long-term care insurance legal settlement elections and benefit reductions and updating our interest rate assumption to reflect the impact of the higher interest rate environment. These refinements were not significant and we believe our assumptions are holding up in the aggregate. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and made no significant changes to our 2022 multi-year in-force rate action plan. However, we did increase the value of our assumption for future approvals and benefit reductions based on recent rate increase approval experience, regulatory support and legal settlement results.

We will continue to regularly review our methodologies and assumptions in light of emerging experience and may be required to make adjustments to our long-term care insurance reserves in the future, which could also impact our loss recognition and cash flow testing results. For a discussion of additional information related to margins for our long-term care insurance business, see “—Critical Accounting Estimates—Future policy benefits.”

During the fourth quarter of 2022, we reviewed our assumptions and methodologies relating to our claim reserves of our long-term care insurance business. As part of our review, we considered emerging experience particularly in mortality and benefit utilization, including the impact of increased cost of care due to inflation. In 2022 and 2021, based on the review of our assumptions and methodologies, we did not make any significant changes to our claim reserves. For a discussion of additional information related to changes to our assumptions and methodologies to our long-term care insurance claim reserves, see “—Critical Accounting Estimates—Liability for policy and contract claims.”

As a result of the review of our claim reserves completed in prior years, we have been establishing higher claim reserves on new claims, which has negatively impacted earnings, and we expect this to continue going forward. Also, average claim reserves for new claims are trending higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on our older long-term care insurance blocks of business will continue to decrease as the blocks run off, we are gaining more experience on our larger new blocks of business and expect continued growth in new claims on these blocks as policyholders reach older attained ages with higher likelihood of going on claim.

In our long-term care insurance products, we have experienced higher mortality during COVID-19 which has had a favorable impact on claim reserves and our operating results. Although it is not our practice to track cause of death for long-term care insurance policyholders and claimants, we believe the higher mortality in our long-term care insurance business in early 2022 as well as during 2021 was likely impacted by COVID-19, but we expect the impacts to be temporary. COVID-19 significantly increased mortality on our most vulnerable claimants, which may reduce mortality rates in future periods. To account for this change in experience due to COVID-19, we adjusted the mortality assumption in our claim reserves to reflect the risk of lower claim termination rates on remaining claims. As of December 31, 2022, the balance of our incremental claim reserves associated with COVID-19 mortality was $90 million, which decreased $44 million from the December 31, 2021 balance of $134 million as mortality decreased for most of 2022 as the impacts from the pandemic subsided.

105

Table of Contents

Short-term mortality experience may fluctuate, and we would decrease the COVID-19 mortality adjustment if we continue to experience lower mortality.

We also experienced lower new claims incidence in our long-term care insurance business during COVID-19. However, we expected this to be temporary and that claims incidence experience would ultimately revert to pre-pandemic trends. As a result, we strengthened our IBNR claim reserves during the height of COVID-19. As of December 31, 2022 and 2021, the balance of IBNR claim reserves due to lower claims incidence was $47 million and $75 million, respectively. We are seeing new claims incidence trending back to pre-pandemic levels. In addition, during the pandemic, a larger share of our claimants sought home care instead of facility-based care, and as the impacts of the pandemic subside, we have seen that trend begin to reverse. We continue to utilize virtual assessments to assess eligibility for benefits while in-person assessments have been temporarily discontinued since the onset of COVID-19. We are reviewing the options to resume in-person assessments, with appropriate protocols in place, while having virtual assessments available for those policyholders who would prefer this option. For claimants without the technology to perform virtual assessments, we have alternate options for gathering information. Our long-term care insurance benefit utilization will be monitored for impact, although it is too early to tell the magnitude and/or direction of that impact.

Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including: premium rate increases and associated benefit reductions on our in-force policies; managing expense levels; executing investment strategies targeting higher returns; and enhancing our financial and actuarial analytical capabilities. In addition, we have reached certain legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. The first legal settlement related to certain of our long-term care insurance policies, which represents approximately 20% of our block, was implemented beginning in 2021 and its implementation was materially completed in the second quarter of 2022. Another similar legal settlement on certain of our long-term care insurance policies, which represents 15% of our block, became final on July 29, 2022. We began implementation of this settlement on August 1, 2022, and recognized modest benefits during the fourth quarter of 2022. Because the election mailings occur on the policyholder’s policy anniversary date, the majority of the impacts are expected to be realized in 2023. However, we do not expect the financial impacts of this settlement to be as significant as they were with the first settlement given the smaller policy block size. On February 15, 2023, the court issued final approval on another similar pending settlement on certain of our long-term care insurance policies, which represents 35% of our block. The judgment will become final 30 days after its entry, or upon final resolution of any timely appeal, and we would expect to begin implementation in the second quarter of 2023. While the two new settlements are similar to the previous settlement, their ultimate impact will depend on the policyholder election rates and the types of reduced benefits elected. Given our experience with the first settlement, we expect these additional settlements to result in an overall net favorable impact to our long-term care insurance business. While we expect renewal premiums to decline over time, the settlements could accelerate that decline if policyholders continue to elect non-forfeiture and reduced benefit options, which have predominantly been the most prevalent policyholder elections for these legal settlements. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to “—Significant Developments and Strategic Highlights—U.S. Life Insurance” and “Item 1—Business—U.S. Life Insurance—In-force rate actions.”

The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.

Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider litigation against states that decline to approve those actuarially

106

Table of Contents

justified rate increases. In January 2022, we began litigation with two states that have refused to approve actuarially justified rate increases.

Life insurance

Results of our life insurance business are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors. We no longer solicit sales of traditional life insurance products; however, we continue to service our existing retained and reinsured blocks of business.

Mortality levels may deviate each period from historical trends. Overall mortality experience was lower in 2022 compared to 2021. In our life insurance products, COVID-19 deaths also declined in 2022 compared to 2021. We have experienced higher mortality than our then-current and priced-for assumptions in recent years for our universal life insurance block. We have also been experiencing higher mortality related charges resulting from an increase in rates charged by our reinsurance partners reflecting natural block aging and higher mortality compared to expectations.

In the fourth quarters of 2022 and 2021, we performed our annual review of life insurance assumptions and loss recognition testing. Our reviews focused on assumptions for mortality, persistency and interest rates, among other assumptions. Our mortality assumption was updated in 2021 to align with the overall pre-COVID-19 experience in later-duration as well as in targeted blocks such as term universal life insurance, conversion policies and post-level term. As of December 31, 2022, the loss recognition testing margin for our term and whole life insurance products was positive and consistent with the 2021 level.

As part of our annual review of assumptions in the fourth quarter of 2022, we recorded a $34 million after-tax benefit in our universal and term universal life insurance products primarily related to higher interest rates. As part of our review in the fourth quarter of 2021, we recorded a $70 million after-tax expense in our universal and term universal life insurance products primarily related to higher pre-COVID-19 mortality experience.

For the year ended December 31, 2022, in connection with our review of DAC for recoverability, we recorded after-tax charges of $41 million in our universal and term universal life insurance products compared to $92 million after-tax charges in 2021. However, there was no recoverability charge in the fourth quarter of 2022 as a result of our favorable assumption update. For a discussion of additional information related to changes to our assumptions and DAC recoverability related to our life insurance business, see “—Critical Accounting Estimates.”

Our mortality experience for older ages is emerging and we continue to monitor trends in mortality improvement. We will continue to regularly review our mortality assumptions as well as all of our other assumptions in light of emerging experience. We may be required to make adjustments in the future to our assumptions which could impact our life insurance reserves. Any materially adverse changes to our assumptions, including mortality, persistency or interest rates, could have a materially negative impact on our results of operations, financial condition and business. For a discussion of additional information related to changes to our life insurance assumptions, see “—Critical Accounting Estimates.”

Compared to 1998 and prior years, we had a significant increase in term life insurance sales between 1999 and 2009, particularly in 1999 and 2000. The blocks of business issued since 2000 vary in size as compared to the large 1999 and 2000 blocks of business. As our large 10-, 15- and 20-year level premium period term life insurance policies written in 1999 and 2000 transitioned to their post-level guaranteed premium rate period, we experienced lower persistency compared to our pricing and valuation assumptions which accelerated DAC amortization in previous years. Our 20-year level premium period business written in 2002 began to enter its post-level period in 2022 and we experienced elevated DAC amortization, albeit lower than the levels we experienced in 2020 and 2019, due to higher-than-expected lapses as these policies exit the level premium period.

107

Table of Contents

Fixed annuities

Results of our fixed annuities business are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels. We no longer solicit sales of traditional fixed annuity products; however, we continue to service our existing retained and reinsured blocks of business.

We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we could see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.

We have previously had premium deficiencies in our single premium immediate annuity products that resulted in the establishment of additional future policy benefit reserves that were reflected as charges to net income. In 2022 and 2021, the results of our loss recognition testing did not result in a premium deficiency; therefore, our liability for future policy benefits was sufficient. The impacts of future adverse changes in our assumptions could result in the establishment of additional future policy benefit reserves and would be immediately reflected as a charge to earnings. For additional information, see “—Critical Accounting Estimates—Future Policy Benefits.”

For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.

Segment results of operations

The following table sets forth the results of operations relating to our U.S. Life Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Premiums$2,773$2,454$2,858$31913%
Net investment income2,7693,0292,878(260)(9)%
Net investment gains (losses)16329517(313)(95)%
Policy fees and other income543565595(22)(4)%
Total revenues6,1016,3776,848(276)(4)%
Benefits and expenses:
Benefits and other changes in policy reserves4,3014,2304,781712%
Interest credited322346383(24)(7)%
Acquisition and operating expenses, net of deferrals1,07886562021325%
Amortization of deferred acquisition costs and intangibles272340418(68)(20)%
Interest expense5%
Total benefits and expenses5,9735,7816,2071923%
Income from continuing operations before income taxes128596641(468)(79)%
Provision for income taxes55155163(100)(65)%
Income from continuing operations73441478(368)(83)%
Adjustments to income from continuing operations:
Net investment (gains) losses, net (1)(17)(330)(525)31395%
Losses on early extinguishment of debt4%
Initial loss from life block transaction92(92)(100)%
Expenses related to restructuring(1)171(18)(106)%
Pension plan termination costs88NM(2)
Taxes on adjustments347110(44)(94)%
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$66$267$68$(201)(75)%
Column 1Column 2
(1)For the years ended December 31, 2022, 2021 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(1) million, $(1) million and $(8) million, respectively.
Column 1Column 2
(2)We define “NM” as not meaningful for increases or decreases greater than 200%.

108

Table of Contents

The following table sets forth adjusted operating income (loss) for the businesses included in our U.S. Life Insurance segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders:
Long-term care insurance$142$445$237$(303)(68)%
Life insurance(148)(269)(247)12145%
Fixed annuities729178(19)(21)%
Total adjusted operating income available to Genworth Financial, Inc.’s common stockholders$66$267$68$(201)(75)%

2022 compared to 2021

Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders

Column 1Column 2Column 3Column 4
Adjusted operating income in our long-term care insurance business decreased $303 million primarily from higher severity and frequency of new claims, lower net investment income and lower terminations as the pandemic impacts lessened in 2022. The decrease was also attributable to a $49 million less favorable impact in 2022 from in-force rate actions approved and implemented, which included a lower net favorable impact from policyholder benefit reduction elections made in connection with legal settlements, as the implementation of one is materially complete and the implementation of another one began in August 2022.
Column 1Column 2Column 3Column 4
The adjusted operating loss in our life insurance business decreased $121 million mainly attributable to a favorable unlocking of $34 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2022 compared to an unfavorable unlocking of $70 million in 2021 (see “—Critical Accounting Estimates” for additional information). The decrease was also attributable to lower mortality as the pandemic impacts subsided and lower DAC impairments of $51 million in 2022. These decreases were partially offset by higher lapses in our 20-year term life insurance block written in 2002 entering its post-level premium period in 2022.
Column 1Column 2Column 3Column 4
Adjusted operating income in our fixed annuities business decreased $19 million mainly attributable to lower net spreads, partially offset by lower DAC amortization and higher mortality in our single premium immediate annuity products in 2022.

Revenues

Premiums

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $51 million primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $93 million of increased premiums in 2022 from in-force rate actions approved and implemented.
Column 1Column 2Column 3Column 4
Our life insurance business increased $370 million primarily driven by lower ceded premiums, partially offset by the continued runoff of our in-force blocks in 2022. In 2021, we initially ceded $360 million of certain term life insurance premiums under a new reinsurance treaty as part of a life block transaction.

109

Table of Contents

Net investment income

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $127 million largely from lower income of $169 million in 2022 mostly attributable to limited partnerships, bond calls and commercial mortgage loan prepayments. The decrease was partially offset by higher income of $18 million related to U.S. Government Treasury Inflation Protected Securities (“TIPS”) and higher average invested assets in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $24 million principally related to $19 million of lower bond calls and commercial mortgage loan prepayments, and lower average invested assets in 2022.
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $109 million largely attributable to lower average invested assets, as well as $35 million of lower bond calls and commercial mortgage loan prepayments in 2022.

Net investment gains (losses)

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $238 million primarily driven by lower net unrealized gains from mark to market adjustments on limited partnerships and changes in the fair value of equity securities in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $69 million primarily due to lower net realized gains on the sale of investment securities in 2022, as well as unrealized losses from changes in the fair value of equity securities and derivative losses in 2022 compared to gains in 2021.

Policy fees and other income. The decrease was largely related to our life insurance business driven mostly by the runoff of our in-force blocks.

Benefits and expenses

Benefits and other changes in policy reserves

Column 1Column 2Column 3Column 4
Our long-term care insurance business increased $344 million primarily due to a less favorable impact of $253 million from reduced benefits in 2022 related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made in connection with legal settlements as the implementation of one is materially complete and the implementation of another one began in August 2022. The increase was also attributable to aging of the in-force block, including higher severity and frequency of new claims, less favorable development on incurred but not reported claims, as well as lower terminations as the impacts of the pandemic lessened in 2022. These increases were partially offset by lower incremental reserves of $244 million recorded in connection with an accrual for profits followed by losses in 2022. To account for the change in experience related to mortality and claim incidence due to COVID-19, we increased claim reserves by $10 million in 2021. As the impacts of COVID-19 lessened, we reduced claim reserves by $72 million in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business increased $135 million largely from higher ceded reinsurance in 2021. We initially ceded $268 million of certain term life insurance reserves under a new reinsurance treaty as part of a life block transaction in 2021. The increase was partially offset by lower mortality and a favorable unlocking of $37 million in our universal and term universal life insurance products as part of our annual review of assumptions in the fourth quarter of 2022 compared to an unfavorable unlocking of $86 million in 2021 (see “—Critical Accounting Estimates—Policyholder account balances” for additional information).
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $408 million principally from lower assumed reserves as a result of a third-party recapture of $374 million of certain single premium immediate annuity contracts and from higher mortality in 2022.

110

Table of Contents

Interest credited. The decrease in interest credited was driven by declines of $18 million in our fixed annuities products and $6 million in our life insurance products due to lower average account values from block runoff.

Acquisition and operating expenses, net of deferrals

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $131 million principally related to lower premium taxes, commissions and other expenses of $98 million in 2022 associated with our in-force rate action plan, which included expenses related to policyholder benefit reduction elections made in connection with legal settlements as the implementation of one is materially complete and the implementation of another one began in August 2022. The decrease was also attributable to restructuring costs of $12 million in 2021 that did not recur and lower operating costs in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $7 million primarily due to lower reinsurance, operating and restructuring costs in 2022. These decreases were partially offset by a $25 million legal settlement expense, $19 million primarily related to conversion costs associated with an outsourcing arrangement and pension plan termination costs of $8 million in 2022.
Column 1Column 2Column 3Column 4
Our fixed annuities business increased $351 million primarily due to a payment of $365 million related to the recapture of certain single premium immediate annuity contracts by a third party in 2022, partially offset by lower operating costs largely due to block runoff.

Amortization of deferred acquisition costs and intangibles

Column 1Column 2Column 3Column 4
Our long-term care insurance business decreased $17 million primarily due to lower policy terminations and policies entering paid-up status in 2022.
Column 1Column 2Column 3Column 4
Our life insurance business decreased $38 million primarily from lower DAC impairments of $65 million on our universal and term universal life insurance products, as well as lower lapses and mortality in 2022, partially offset by higher lapses in our 20-year term life insurance block written in 2002 entering its post-level premium period.
Column 1Column 2Column 3Column 4
Our fixed annuities business decreased $13 million primarily due to higher interest rates in 2022 that are expected to increase future investment spreads.

Provision for income taxes. The effective tax rate was 43.3% and 26.1% for the years ended December 31, 2022 and 2021, respectively. The increase in the effective tax rate was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income, in relation to lower pre-tax income in 2022.

U.S. Life Insurance selected operating performance measures

Long-term care insurance

As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions on older generation blocks of business in order to bring those blocks closer to a break-even point over time and reduce the strain on earnings and capital. We are also requesting premium rate increases and associated benefit reductions on newer blocks of business, as needed, some of which may be significant, to help bring their loss ratios back towards their original pricing. In aggregate, we estimate that we have achieved approximately $23.5 billion, on a net present value basis, of approved in-force rate increases since 2012. We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases and associated benefit reductions in order to pay future claims.

111

Table of Contents

The following table summarizes the impact from cumulative in-force rate actions on the results of operations of our long-term care insurance business for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Premiums$923$830$746$9311%
Plus: Benefits and other changes in policy reserves(1)659912507(253)(28)%
Less: Acquisition and operating expenses, net of deferrals(2)18428262(98)(35)%
Adjusted operating income before taxes1,3981,4601,191(62)(4)%
Income taxes294307250(13)(4)%
Adjusted operating income(3)$1,104$1,153$941$(49)(4)%
Column 1Column 2
(1)Amounts represent benefit reductions elected by policyholders as an alternative to increased premiums. These amounts reduced benefits and other changes in policy reserves in our long-term care insurance business for the periods indicated.
Column 1Column 2
(2)Amounts include premium taxes, commissions and other expenses associated with our long-term care insurance in-force rate action plan, which included expenses of $104 million and $209 million for the years ended December 31, 2022 and 2021, respectively, related to policyholder benefit reduction elections made in connection with legal settlements. Included in the $104 million and $209 million of expenses for the years ended December 31, 2022 and 2021, respectively, was $96 million and $185 million, respectively, of cash damages. The implementation of one legal settlement is materially complete and the implementation of another one began in August 2022.
Column 1Column 2
(3)Adjusted operating income available to Genworth Financial, Inc.’s common stockholders attributable to in-force rate actions excludes reserve updates resulting from profits followed by losses and reserve changes for group products.

See our results of operations above for additional details.

The following table presents net earned premiums and the loss ratio for our long-term care insurance business for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Net earned premiums:
Individual long-term care insurance(1)$2,405$2,466$2,497$(61)(2)%
Group long-term care insurance134124123108%
Total$2,539$2,590$2,620$(51)(2)%
Loss ratio75%61%71%14%
Column 1Column 2
(1)For the years ended December 31, 2022, 2021 and 2020, amounts include increased premiums of $923 million, $830 million and $746 million, respectively, from in-force rate actions approved and implemented.

The loss ratio is the ratio of benefits and other changes in reserves less tabular interest on reserves less loss adjustment expenses to net earned premiums.

Net earned premiums decreased in 2022 compared to 2021 primarily driven by lower renewal premiums from policy terminations and policies entering paid-up status, partially offset by $93 million of increased premiums in 2022 from in-force rate actions approved and implemented.

112

Table of Contents

The loss ratio increased in 2022 compared to 2021 due to higher benefits and other changes in reserves and lower premiums in 2022 as discussed above.

Life insurance

The following table sets forth selected operating performance measures regarding our life insurance business as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Term and whole life insurance
Net earned premiums (1)$234$(136)$238$370NM(2)
Life insurance in-force, net of reinsurance48,16247,29759,9198652%
Life insurance in-force before reinsurance300,145332,793362,082(32,648)(10)%
Term universal life insurance
Net deposits$187$203$217$(16)(8)%
Life insurance in-force, net of reinsurance92,71999,471107,048(6,752)(7)%
Life insurance in-force before reinsurance93,336100,119107,774(6,783)(7)%
Universal life insurance
Net deposits$245$259$269$(14)(5)%
Life insurance in-force, net of reinsurance29,79831,11732,501(1,319)(4)%
Life insurance in-force before reinsurance33,62235,22836,839(1,606)(5)%
Total life insurance
Net earned premiums and deposits (1)$666$326$724$340104%
Life insurance in-force, net of reinsurance170,679177,885199,468(7,206)(4)%
Life insurance in-force before reinsurance427,103468,140506,695(41,037)(9)%
Column 1Column 2
(1)In the fourth quarter of 2021, we initially ceded premiums of $360 million associated with certain term life insurance policies under a new reinsurance treaty as part of a life block transaction.
Column 1Column 2
(2)We define “NM” as not meaningful for increases or decreases greater than 200%.

We no longer solicit sales of our traditional life insurance products; however, we continue to service our existing blocks of business.

Term and whole life insurance

Net earned premiums increased in 2022 compared to 2021 mainly attributable to lower ceded premiums in 2022, partially offset by the continued runoff of our in-force blocks. In 2021, we initially ceded $360 million of certain term life insurance premiums under a new reinsurance treaty as part of a life block transaction.

Universal and term universal life insurance

Net deposits decreased in 2022 compared to 2021 primarily attributable to lower renewals in 2022 and from the continued runoff of our in-force blocks.

113

Table of Contents

Fixed annuities

The following table sets forth selected operating performance measures regarding our fixed annuities business as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Account value, beginning of period$10,163$11,815$13,023$(1,652)(14)%
Deposits728380(11)(13)%
Surrenders, benefits and product charges (1)(2,015)(1,976)(1,886)(39)(2)%
Net flows(1,943)(1,893)(1,806)(50)(3)%
Interest credited and investment performance257349405(92)(26)%
Effect of accumulated net unrealized investment gains (losses)(627)(108)193(519)NM(2)
Account value, end of period$7,850$10,163$11,815$(2,313)(23)%
Column 1Column 2
(1)Amount included the recapture of $373 million account value of certain single premium immediate annuities by a third party during 2022.
Column 1Column 2
(2)We define “NM” as not meaningful for increases or decreases greater than 200%.

We no longer solicit sales of our traditional fixed annuity products; however, we continue to service our existing block of business.

Account value as of December 31, 2022 decreased compared to December 31, 2021 driven mostly by surrenders and benefits, which included the recapture of $373 million of certain single premium immediate annuity contracts by a third party in 2022. The decrease compared to December 31, 2021 was also attributable to unfavorable market performance, partially offset by interest credited in 2022.

Runoff segment

Trends and conditions

Results of our Runoff segment are affected primarily by investment performance, interest rate levels, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our Runoff segment can significantly impact our regulatory capital requirements, distributable earnings and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate the impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.

Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity and interest rate market performance and volatility could result in additional gains or losses in these products although associated hedging activities are expected to partially mitigate these impacts.

114

Table of Contents

Segment results of operations

The following table sets forth the results of operations relating to our Runoff segment for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Net investment income$214$194$210$2010%
Net investment gains (losses)(16)3(26)(19)NM(1)
Policy fees and other income114134130(20)(15)%
Total revenues312331314(19)(6)%
Benefits and expenses:
Benefits and other changes in policy reserves352748830%
Interest credited1811621661912%
Acquisition and operating expenses, net of deferrals425348(11)(21)%
Amortization of deferred acquisition costs and intangibles232023315%
Total benefits and expenses281262285197%
Income from continuing operations before income taxes316929(38)(55)%
Provision for income taxes5134(8)(62)%
Income from continuing operations265625(30)(54)%
Adjustments to income from continuing operations:
Net investment (gains) losses, net (2)14(3)2317NM(1)
Taxes on adjustments(3)1(5)(4)NM(1)
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders$37$54$43$(17)(31)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.
Column 1Column 2
(2)For the years ended December 31, 2022 and 2020, net investment (gains) losses were adjusted for DAC and other intangible amortization and certain benefit reserves of $(2) million and $(3) million, respectively.

2022 compared to 2021

Adjusted operating income available to Genworth Financial, Inc.’s common stockholders

Adjusted operating income decreased predominantly due to the impact from unfavorable equity market performance and higher interest rates on our variable annuity products in 2022.

Revenues

Net investment income increased primarily from higher policy loan income in our corporate-owned life insurance products in 2022.

Net investment losses in 2022 were predominantly related to derivative losses, partially offset by gains on embedded derivatives associated with our variable annuity products with GMWBs. Net investment gains in 2021 were predominantly related to gains on embedded derivatives associated with our variable annuity products with GMWBs and net gains from the sale of investment securities, partially offset by derivative losses.

Policy fees and other income decreased principally from lower fee income driven mostly by a decline in the average account values in our variable annuity products in 2022.

115

Table of Contents

Benefits and expenses

Benefits and other changes in policy reserves increased primarily attributable to higher GMDB reserves in our variable annuity products due to unfavorable equity market performance and higher interest rates in 2022.

Interest credited increased largely due to our corporate-owned life insurance products in 2022.

Acquisition and operating expenses, net of deferrals, decreased principally from lower commissions and operating costs in our variable annuity products in 2022 due to block runoff.

Amortization of deferred acquisition costs and intangibles increased primarily from higher DAC amortization in our variable annuity products due to unfavorable equity market performance in 2022.

Provision for income taxes. The effective tax rate decreased to 14.9% for the year ended December 31, 2022 from 18.5% for the year ended December 31, 2021. The decrease was primarily attributable to tax benefits from tax favored items in relation to lower pre-tax income in 2022.

Runoff selected operating performance measures

Variable annuity and variable life insurance products

The following table sets forth selected operating performance measures regarding our variable annuity and variable life insurance products as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Account value, beginning of period$4,839$5,001$5,042$(162)(3)%
Deposits161920(3)(16)%
Surrenders, benefits and product charges(463)(607)(559)14424%
Net flows(447)(588)(539)14124%
Interest credited and investment performance(730)426498(1,156)NM(1)
Account value, end of period$3,662$4,839$5,001$(1,177)(24)%
Column 1Column 2
(1)We define “NM” as not meaningful for increases or decreases greater than 200%.

We no longer solicit sales of our variable annuity or variable life insurance products; however, we continue to service our existing blocks of business and accept additional deposits on existing contracts and policies.

Account value as of December 31, 2022 decreased compared to December 31, 2021 primarily related to unfavorable equity market performance and surrenders in 2022.

116

Table of Contents

Funding agreements

The following table presents the account value of our funding agreements as of and for the dates indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Account value, beginning of period$250$300$253$(50)(17)%
Deposits150%
Surrenders and benefits(53)(52)(106)(1)(2)%
Net flows(53)(52)44(1)(2)%
Interest credited323150%
Account value, end of period$200$250$300$(50)(20)%

Account value as of December 31, 2022 decreased compared to December 31, 2021 from a principal payment of $50 million.

Corporate and Other Activities

Results of operations

The following table sets forth the results of operations relating to Corporate and Other activities for the periods indicated:

Years ended December 31,Increase (decrease) and percentage change
(Amounts in millions)2022202120202022 vs. 2021
Revenues:
Premiums$6$6$7$%
Net investment income866233%
Net investment gains (losses)(15)(7)5(8)(114)%
Policy fees and other income1(2)(1)(100)%
Total revenues(1)616(7)(117)%
Benefits and expenses:
Benefits and other changes in policy reserves14(1)(100)%
Acquisition and operating expenses, net of deferrals247561(51)(68)%
Amortization of deferred acquisition costs and intangibles21(2)(100)%
Interest expense54109172(55)(50)%
Total benefits and expenses78187238(109)(58)%
Loss from continuing operations before income taxes(79)(181)(222)10256%
Benefit for income taxes(15)(53)(39)3872%
Loss from continuing operations(64)(128)(183)6450%
Adjustments to loss from continuing operations:
Net investment (gains) losses157(5)8114%
Losses on early extinguishment of debt6455(39)(87)%
Expenses related to restructuring142(14)(100)%
Taxes on adjustments(5)(14)(1)964%
Adjusted operating loss available to Genworth Financial Inc.’s common stockholders$(48)$(76)$(182)$2837%

117

Table of Contents

2022 compared to 2021

Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders

The adjusted operating loss decreased primarily related to lower interest expense, partially offset by tax benefits of $21 million in 2021 from a reduction in uncertain tax positions due to the expiration of certain statute of limitations that did not recur.

Revenues

The increase in net investment losses was primarily related to net realized losses from the sale of investment securities in 2022 compared to net realized gains in 2021, partially offset by derivative gains in 2022 compared to derivative losses in 2021.

Benefits and expenses

Acquisition and operating expenses, net of deferrals, decreased mainly driven by $24 million of lower make-whole premiums on the early redemption of Genworth Holdings’ senior notes and $15 million of lower net losses related to the repurchase of Genworth Holdings’ senior notes in 2022, as well as $14 million of restructuring costs in 2021 that did not recur.

Interest expense decreased largely driven by the early redemption and repurchase of Genworth Holdings’ senior notes due in September 2021, August 2023 and February 2024, partially offset by a higher floating rate of interest on Genworth Holdings’ junior subordinated notes in 2022.

The decrease in the benefit for income taxes was primarily related to a reduction in uncertain tax positions due to the expiration of certain statute of limitations in 2021 that did not recur, as well as a lower pre-tax loss in 2022.

Investments and Derivative Instruments

General macroeconomic environment

The stability of both the financial markets and global economies in which we operate impacts the sales, revenue growth and profitability trends of our businesses as well as the value of assets and liabilities.

Varied levels of economic performance, coupled with uncertain economic outlooks, war and geopolitical tensions, changes in government policy, including monetary policy, global trade, regulatory and tax reforms, and other changes in market conditions, such as inflation, will continue to influence investment and spending decisions by consumers and businesses as they adjust their consumption, debt, capital and risk profiles in response to these conditions. These trends change as investor confidence in the markets and the outlook for some consumers and businesses shift. As a result, our sales, revenues and profitability trends of certain insurance and investment products as well as the value of assets and liabilities could be impacted going forward. In particular, government responses and displacements caused by COVID-19, including government stimulus, government spending, monetary policies (such as quantitative tightening), the volatility and strength of the capital markets, changes in tax policy and/or in U.S. tax legislation, inflation, including the price of oil, supply chain shortages, international trade and the impact of global financial regulation reform will continue to affect economic and business outlooks, level of interest rates, consumer confidence and consumer behavior moving forward.

During the fourth quarter of 2022, the U.S. Federal Reserve continued to aggressively address elevated inflation by increasing interest rates. The U.S. Federal Reserve increased interest rates by 75 basis points at its meeting held in November 2022 and by 50 basis points in December 2022, with an additional increase of 25 basis points in February 2023, bringing the target range to the highest level since 2007. An imbalance of supply

118

Table of Contents

and demand, a tightening labor market, supply chain disruptions, rising commodity prices and increased housing costs, as well as the Russian invasion of Ukraine and subsequent sanctions from the United States and Western Europe, contributed to the rise in inflation throughout 2022. The consumer price index peaked above 9% during the first half of 2022 but slowed for six consecutive months during the second half of 2022 with annual inflation of 6.5% as of December 31, 2022. A strong labor market partially offset some of the inflationary pressures in the economy, with the unemployment rate in line with pre-COVID-19 levels and job creation steady in the fourth quarter of 2022.

Gross domestic product contracted in the first half of 2022 due in part to elevated inflation pressure on consumers, monetary tightening and persistent supply chain disruptions, but increased modestly in the second half of 2022, reflecting increases in exports and government consumption, as well as consumer spending supported by a strong labor market. Given the persistent high inflation, supply chain disruptions, evolving U.S. Federal Reserve monetary policy, including the expectation of continued higher interest rates, and prolonged geopolitical tensions, it is possible the U.S. economy could fall into a recession in 2023. Specific to Genworth, we continue to closely monitor the operating results and financial position of Enact Holdings, particularly related to emerging housing trends. If housing trends move in an unfavorable direction in contrast to our current projections, our liquidity, financial position and results of operations could be adversely impacted. See “—Enact segment—Trends and conditions” for additional information.

Trends and conditions

Investments

U.S. Treasury yields fluctuated during the fourth quarter of 2022 driven by economic data releases and monetary policy actions by the U.S. Federal Reserve. The U.S. Treasury yield for shorter maturities increased during the fourth quarter of 2022 in line with actual and expected interest rate increases by the U.S. Federal Reserve. The differential between the two-year and ten-year U.S. Treasury yield continued to invert during the fourth quarter of 2022 as the two-year U.S. Treasury yield rose even higher than the ten-year U.S. Treasury yield. The thirty-year U.S. Treasury yield also rose higher than the ten-year U.S. Treasury yield as of December 31, 2022, normalizing the long-term end of the curve.

Credit markets performed well during the fourth quarter of 2022 due to a reduction in interest rate volatility driven by market clarity on monetary policy, as well as reduced macroeconomic pressures as a result of a strong labor market and moderating inflation. The improved economic environment allowed corporate borrowers to access capital markets with an increase in public corporate bond issuance, and investment grade credit spreads were lower during the fourth quarter of 2022.

As of December 31, 2022, our investment portfolio had no direct exposure to Russia or Ukraine. At this time, we do not believe there is a material risk to the valuation of our investment portfolio due to credit losses or direct write-offs that may arise as a result of the conflict.

As of December 31, 2022, our fixed maturity securities portfolio, which was 96% investment grade, comprised 77% of our total invested assets and cash.

Derivatives

As of December 31, 2022, $1.4 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2022, we posted initial margin of $71 million to our clearing agents, which represented approximately $36 million more than was otherwise required by the clearinghouse. Because our clearing agents

119

Table of Contents

serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. As of December 31, 2022, $9.6 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $437 million and are holding collateral from counterparties in the amount of $21 million.

In July 2017, the United Kingdom Financial Conduct Authority announced its intention to transition away from London Interbank Offered Rate (“LIBOR”), with its full elimination to occur after 2021. The LIBOR tenors, such as the three-month LIBOR, have various phase-out dates with the last committed publication date of June 30, 2023. The Alternate Reference Rate Committee (“ARRC”), convened by the Board of Governors of the Federal Reserve System and the New York Federal Reserve Bank, has endorsed the Secured Overnight Financing Rate (“SOFR”) as its preferred replacement benchmark for U.S. dollar LIBOR. SOFR is calculated and published by the New York Federal Reserve Bank and reflects the combination of three overnight U.S. Treasury Repo Rates. The rate is different from LIBOR, in that it is a risk-free rate, is backward-looking instead of forward-looking, is a secured rate and currently is available primarily as an overnight rate rather than a one-, three- or six-month rate available for LIBOR.

We completed our assessment of operational readiness for LIBOR cessation related to our various instruments in 2021 and will continue to monitor the process of elimination and replacement of LIBOR, including any new accounting pronouncements that may be issued to provide further transition relief due to the extended cessation dates of certain LIBOR tenors. Since the initial announcement, we have terminated the majority of our LIBOR-based swaps and entered into alternative rate swaps. In anticipation of the elimination of LIBOR, we plan to continue to convert most of our remaining LIBOR-based derivatives in a similar manner. Moreover, we will continue to monitor the developments coming from ARRC, who is expected to authorize the use of an alternative rate to replace the current contractual three-month LIBOR rate applied to Genworth Holdings’ junior subordinated notes due in 2066. Although uncertainty remains surrounding the final cessation and transition away from LIBOR, we do not expect a material adverse impact on our results of operations or financial condition.

Investment results

The following table sets forth information about our investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:

Increase (decrease)
2022202120202022 vs. 2021
(Amounts in millions)YieldAmountYieldAmountYieldAmountYieldAmount
Fixed maturity securities—taxable4.5%$2,2964.5%$2,4114.7%$2,448%$(115)
Fixed maturity securities—non-taxable4.7%55.6%74.3%6(0.9)%(2)
Equity securities4.0%104.0%94.2%12%1
Commercial mortgage loans4.6%3215.5%3765.0%345(0.9)%(55)
Policy loans10.0%2119.3%1899.5%1990.7%22
Limited partnerships (1)4.7%9915.7%2239.1%72(11.0)%(124)
Other invested assets (2)59.9%26769.7%24156.0%223(9.8)%26
Cash, cash equivalents, restricted cash and short-term investments1.2%20%10.5%151.2%19
Gross investment income before expenses and fees5.0%3,2295.2%3,4575.0%3,320(0.2)%(228)
Expenses and fees(0.2)%(83)(0.1)%(87)(0.1)%(93)(0.1)%4
Net investment income4.8%$3,1465.1%$3,3704.9%$3,227(0.3)%$(224)
Average invested assets and cash$65,160$66,099$65,982$(939)
Column 1Column 2
(1)Limited partnership investments are primarily equity-based and do not have fixed returns by period.
Column 1Column 2
(2)Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation.

120

Table of Contents

Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments and securities lending activity, which was included in other invested assets prior to the suspension of our securities lending program in the third quarter of 2021 and was calculated net of the corresponding securities lending liability.

Gross annualized weighted-average investment yields decreased in 2022 compared to 2021 primarily driven by lower net investment income on lower average invested assets. Net investment income included $124 million of lower limited partnership income and $106 million of lower bond calls and commercial mortgage loan prepayments, partially offset by $18 million of higher income related to inflation-driven volatility on TIPS in 2022.

The following table sets forth net investment gains (losses) for the years ended December 31:

(Amounts in millions)202220212020
Realized investment gains (losses):
Available-for-sale fixed maturity securities:
Realized gains$28$67$471
Realized losses(102)(10)(29)
Net realized gains (losses) on available-for-sale fixed maturity securities(74)57442
Net realized gains (losses) on equity securities sold(7)(1)
Net realized gains (losses) on limited partnerships3
Total net realized investment gains (losses)(74)53441
Net change in allowance for credit losses on available-for-sale fixed maturity securities(6)(5)
Write-down of available-for-sale fixed maturity securities(2)(1)(4)
Net unrealized gains (losses) on equity securities still held(35)14
Net unrealized gains (losses) on limited partnerships71264112
Commercial mortgage loans4(3)(2)
Derivative instruments1714(49)
Other21(5)
Net investment gains (losses)$(17)$323$492

2022 compared to 2021

Column 1Column 2Column 3Column 4
We recorded net realized losses related to the sale of available-for-sale fixed maturity securities of $74 million in 2022 compared to net realized gains of $57 million in 2021 primarily driven by sales of U.S. corporate securities to manage asset exposure and to optimize cash at Genworth Holdings in 2022.
Column 1Column 2Column 3Column 4
We recorded $193 million of lower net unrealized gains on limited partnerships in 2022 compared to 2021 primarily from less favorable private equity market performance in 2022. We also recorded $35 million of net unrealized losses on equity securities during 2022 driven by unfavorable equity market performance.

121

Table of Contents

Investment portfolio

The following table sets forth our cash, cash equivalents and invested assets as of December 31:

20222021
(Amounts in millions)Carrying value% of totalCarrying value% of total
Available-for-sale fixed maturity securities:
Public$31,75753%$42,50158%
Private14,8262417,97924
Equity securities3191198
Commercial mortgage loans, net7,010116,8309
Policy loans2,13932,0503
Limited partnerships2,33141,9003
Other invested assets56618201
Cash, cash equivalents and restricted cash1,79931,5712
Total cash, cash equivalents and invested assets$60,747100%$73,849100%

For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for this line item under “—Consolidated Balance Sheets.” See note 4 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.

We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2022, approximately 7% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 16 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.

122

Table of Contents

Fixed maturity securities

As of December 31, 2022, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows:

(Amounts in millions)Amortized cost or costGross unrealized gainsGross unrealized lossesAllowance for credit lossesFair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises$3,446$86$(191)$$3,341
State and political subdivisions2,72619(346)2,399
Non-U.S. government73115(101)645
U.S. corporate:
Utilities4,29550(447)3,898
Energy2,45033(221)2,262
Finance and insurance8,00559(871)7,193
Consumer—non-cyclical4,77684(403)4,457
Technology and communications3,26543(361)2,947
Industrial1,31215(130)1,197
Capital goods2,29041(193)2,138
Consumer—cyclical1,75814(155)1,617
Transportation1,16532(97)1,100
Other3253(18)310
Total U.S. corporate29,641374(2,896)27,119
Non-U.S. corporate:
Utilities817(77)740
Energy1,00919(68)960
Finance and insurance2,12430(208)1,946
Consumer—non-cyclical6551(90)566
Technology and communications9974(107)894
Industrial8808(70)818
Capital goods6063(63)546
Consumer—cyclical308(32)276
Transportation39212(29)375
Other93215(58)889
Total non-U.S. corporate8,72092(802)8,010
Residential mortgage-backed1,0597(71)995
Commercial mortgage-backed2,1832(277)1,908
Other asset-backed2,3281(163)2,166
Total available-for-sale fixed maturity securities$50,834$596$(4,847)$$46,583

123

Table of Contents

As of December 31, 2021, the amortized cost or cost, gross unrealized gains (losses), allowance for credit losses and fair value of our fixed maturity securities classified as available-for-sale were as follows:

(Amounts in millions)Amortized cost or costGross unrealized gainsGross unrealized lossesAllowance for credit lossesFair value
Fixed maturity securities:
U.S. government, agencies and government-sponsored enterprises$3,368$1,184$$$4,552
State and political subdivisions2,982474(6)3,450
Non-U.S. government76286(13)835
U.S. corporate:
Utilities4,330783(9)5,104
Energy2,581363(10)2,934
Finance and insurance8,0031,012(24)8,991
Consumer—non-cyclical5,1381,029(8)6,159
Technology and communications3,345476(13)3,808
Industrial1,322175(3)1,494
Capital goods2,334415(4)2,745
Consumer—cyclical1,703203(7)1,899
Transportation1,1222491,371
Other37941(1)419
Total U.S. corporate30,2574,746(79)34,924
Non-U.S. corporate:
Utilities86763(2)928
Energy1,194190(1)1,383
Finance and insurance2,171270(9)2,432
Consumer—non-cyclical66481(2)743
Technology and communications1,085166(1)1,250
Industrial933117(3)1,047
Capital goods64066(1)705
Consumer—cyclical31627(2)341
Transportation42268(1)489
Other1,052169(4)1,217
Total non-U.S. corporate9,3441,217(26)10,535
Residential mortgage-backed1,325116(1)1,440
Commercial mortgage-backed2,435152(3)2,584
Other asset-backed2,13829(7)2,160
Total available-for-sale fixed maturity securities$52,611$8,004$(135)$$60,480

Fixed maturity securities decreased $13.9 billion primarily as a result of a change from net unrealized investment gains in 2021 to net unrealized investment losses in 2022 due to an increase in interest rates, as well as from net sales and maturities in 2022.

124

Table of Contents

Other invested assets

The following table sets forth the carrying values of our other invested assets as of December 31:

20222021
(Amounts in millions)Carrying value% of totalCarrying value% of total
Bank loan investments$46782%$36345%
Derivatives50941450
Short-term investments31263
Other investments468172
Total other invested assets$566100%$820100%

Derivatives decreased largely from an increase in interest rates in 2022. Bank loan investments increased from funding of additional investments, partially offset by principal repayments in 2022.

Derivatives

The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB embedded derivatives, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:

(Notional in millions)MeasurementDecember 31, 2021AdditionsMaturities/ terminationsDecember 31, 2022
Derivatives designated as hedges
Cash flow hedges:
Interest rate swapsNotional$7,653$1,109$(220)$8,542
Foreign currency swapsNotional12717144
Total cash flow hedges7,7801,126(220)8,686
Total derivatives designated as hedges7,7801,126(220)8,686
Derivatives not designated as hedges
Equity index optionsNotional1,446946(1,456)936
Financial futuresNotional9464,405(3,948)1,403
Other foreign currency contractsNotional83(83)
Total derivatives not designated as hedges2,4755,351(5,487)2,339
Total derivatives$10,255$6,477$(5,707)$11,025
(Number of policies)MeasurementDecember 31, 2021AdditionsMaturities/ terminationsDecember 31, 2022
Derivatives not designated as hedges
GMWB embedded derivativesPolicies21,804(1,876)19,928
Fixed index annuity embedded derivativesPolicies9,344(2,029)7,315
Indexed universal life embedded derivativesPolicies806(35)771

The increase in the notional value of derivatives was primarily attributable to the addition of interest rate swaps that support our long-term care insurance business and financial futures forecasted to be used to hedge changes in the fair value of MRBs under LDTI effective for us on January 1, 2023, partially offset by the

125

Table of Contents

termination of equity index options used to protect statutory surplus from equity market fluctuations. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to new accounting guidance.

The number of policies related to our embedded derivatives decreased as these products are no longer being offered and continue to runoff.

Critical Accounting Estimates

The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” In addition, the impact of new accounting guidance related to long-duration insurance contracts, commonly known as LDTI, that will be effective for us on January 1, 2023, will include significant changes to our consolidated financial statements. These changes will include updates to our future estimates and assumptions used to measure our insurance assets and liabilities for long-duration insurance contracts beginning on January 1, 2023 and applied to our historic comparative periods that will be re-presented commencing on the Transition Date. However, these changes are not effective for this annual report on Form 10-K, and accordingly, are not included in our critical accounting estimates herein. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

Insurance liabilities and reserves. We calculate and maintain reserves for the estimated future payment of claims to our policyholders and contractholders based on actuarial assumptions and in accordance with U.S. GAAP and industry practice. We build these reserves as the estimated value of those obligations increases, and we release these reserves as those future obligations are paid, experience changes or policies lapse. The reserves we establish reflect estimates and actuarial assumptions and methodologies with regard to our future experience, involve the exercise of significant judgment and are inherently uncertain. Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our reserves as well as the assumptions originally used in pricing our products.

Many factors, and changes in these factors, can affect future experience including, but not limited to: interest rates; investment returns and volatility; economic and social conditions, such as inflation, unemployment, home price appreciation or depreciation, and healthcare experience; policyholder persistency or lapses; insured mortality; insured morbidity; future premium rate increases and associated benefit reductions; expenses; and doctrines of legal liability and damage awards in litigation. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Moreover, we may not be able to mitigate the impact of unexpected adverse experience by increasing premiums and/or other charges to policyholders (where we have the right to do so) or by offering benefit reductions as an alternative to increasing premiums.

Future policy benefits

The liability for future policy benefits is equal to the present value of expected future benefits and expenses, less the present value of expected future net premiums based on assumptions including projected interest rates and investment returns, health care experience, policyholder persistency or lapses, insured mortality, insured morbidity and expenses, all of which are locked-in at the time the policies are issued or acquired. In our long-

126

Table of Contents

term care insurance business, our assumptions used in loss recognition testing also include significant premium rate increases and associated benefit reductions that have been filed and approved or are anticipated to be approved (including premium rate increases and associated benefit reductions not yet filed). The liability for future policy benefits is reviewed at least annually as a part of our loss recognition testing using current assumptions based on the manner of acquiring, servicing and measuring the profitability of the insurance contracts. Loss recognition testing is generally performed at the line of business level, with acquired blocks tested separately. If loss recognition testing indicates a premium deficiency, the liability for future policy benefits is measured using updated assumptions, which become the new locked-in assumptions utilized going forward unless another premium deficiency charge is recorded.

See notes 2 and 9 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to insurance reserves.

Long-term care insurance block, excluding our acquired block

We annually perform loss recognition testing for the liability for future policy benefits for our long-term care insurance products in the aggregate, excluding our acquired block of long-term care insurance, which is tested separately. The results of loss recognition testing are driven by changes to assumptions and methodologies primarily impacting claim termination rates, incidence and benefit utilization rates, mortality and lapse rates, as well as in-force rate actions. Claim termination rates refer to the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. As of December 31, 2022 and 2021, the liability for future policy benefits associated with our long-term care insurance block, excluding the acquired block, was $25.0 billion and $26.6 billion, respectively.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance loss recognition testing margin was as follows for the periods presented:

Other block (excluding the acquired block)Increase (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates and assumptions used in loss recognition testing:
Present value of expected future benefits$49,452$49,495$(43)%
Future in-force rate action assumption$6,800$9,000$(2,200)(24)%
Discount rate assumption5.32%5.25%70/0001%

In 2022 and 2021, the results of our loss recognition testing on our long-term care insurance block, excluding the acquired block, indicated that our DAC was recoverable and reserves were sufficient, with a margin of approximately $400 million to $850 million as of December 31, 2022 compared to approximately $450 million to $900 million as of December 31, 2021. All key assumptions were reviewed in 2022 and 2021 and updated where appropriate. For the fourth quarter of 2022 review, we refined several assumptions, including reducing our lapse assumption in light of favorable experience from our long-term care insurance settlement elections and benefit reductions and updating our interest rate assumption to reflect the impact of the higher interest rate environment. These refinements were not significant, and we believe our assumptions are holding up in the aggregate. We also evaluated our assumptions regarding expectations of future premium rate increase approvals and benefit reductions and made no significant changes to our 2022 multi-year in-force rate action plan. However, we did increase the value of our assumption for future approvals and benefit reductions based on recent rate increase approval experience, regulatory support and legal settlement results. As margins remained positive, there was no reserve strengthening required, and therefore no resulting charge to net income.

127

Table of Contents

The decrease in the present value of expected future benefits was primarily attributable to actual benefit reductions in 2022 and expected future benefit reductions associated with our in-force rate action plan (among other factors), mostly offset by unfavorable assumption updates, most notably higher cost of care driven by elevated inflation.

Our assumption for future in-force rate actions is based on our best estimate of the rate increases we expect given our current plans for rate increase filings and our historical experience regarding rate increase approvals. The decrease in future in-force rate actions in 2022 compared to 2021 reflects in-force rate actions approved and implemented during 2022, partially offset by expected future in-force rate actions not yet filed, including in connection with the impacts from assumption updates. An increase in the expected amount of in-force rate actions would favorably impact the results of our long-term care insurance margin testing, whereas any unexpected reduction in the amount of in-force rate actions would negatively impact our margins.

We assume a static discount rate that is in line with our current portfolio yield. This rate represents our expected investment returns based on the portfolio of assets supporting the net U.S. GAAP liability as of the calculation date and, therefore, excludes the impacts of qualifying hedge gains that are not currently amortizing. Because the discount rate is based on our current portfolio yields, changes in interest rates do not impact our loss recognition testing margins unless they result in changes to investment yields. Returns on new investments would need to exceed our current portfolio yield to benefit loss recognition testing margins.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 long-term care insurance loss recognition testing margin:

(Amounts in millions)Other block (excluding the acquired block)
Sensitivities on loss recognition testing: (1)
5% relative increase in future claim costs$(2,475)
10% reduction in benefit of future in-force rate actions$(680)
Discount rate decrease of 25 basis points (2)$(1,125)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another. For example, the increase in claim costs does not include any offsetting impacts from potential future in-force rate actions. Any such offset from in-force rate actions would primarily impact our long-term care insurance block, excluding the acquired block.
Column 1Column 2
(2)The 25 basis point decrease in the discount rate refers to a reduction in our portfolio yields.

Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding expense recognized in net income (loss). Our positive margin for our long-term care insurance block, excluding the acquired block, is dependent on our assumptions regarding our ability to successfully implement our in-force rate action strategy involving premium rate increases and associated benefit reductions. For our long-term care insurance block, excluding the acquired block, any adverse changes in assumptions would only be reflected in net income (loss) as a loss to the extent the margin was reduced below zero.

Profits followed by losses

With respect to our long-term care insurance block, excluding the acquired block, while loss recognition testing supports that in the aggregate our reserves are sufficient, our future projections indicate we have projected profits in earlier periods followed by projected losses in later periods. As a result of this pattern of projected profits followed by projected losses, we have ratably accrued additional future policy benefit reserves over the profitable periods by the amounts necessary to offset estimated losses during the periods that follow. Such

128

Table of Contents

additional reserves are updated each period and calculated based on our estimate of the amount necessary to offset the losses in future periods utilizing expected income and current best estimate assumptions based on actual and anticipated experience, consistent with our loss recognition testing. We adjust the accrual rate prospectively, over the remaining profitable periods, without any catch-up adjustment. During the years ended December 31, 2022 and 2021, we increased our long-term care insurance future policy benefit reserves by $405 million and $649 million, respectively, to accrue for profits followed by losses. As of December 31, 2022 and 2021, the total amount accrued for profits followed by losses was $1.7 billion and $1.3 billion, respectively. The accrual is recorded quarterly and is impacted by the pattern and present value of expected future losses which are updated annually at the time in which we perform loss recognition testing. During the fourth quarter of 2022, we updated our loss recognition testing assumptions, which included changes from our annual assumption review completed in the fourth quarter of 2022, as well as updates to our future in-force rate actions. The present value of expected future losses was approximately $2.3 billion and $2.5 billion as of December 31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, we estimate a factor of approximately 79% and 76%, respectively, of those profits on our long-term care insurance block, excluding the acquired block, will be accrued in the future to offset estimated future losses during later periods. The factor increased compared to December 31, 2021 due mostly to lower actual profits in 2022 resulting in a need to accelerate the accrual for incremental future policy benefits for profits followed by losses.

Acquired block of long-term care insurance

As of December 31, 2022 and 2021, the liability for future policy benefits associated with our acquired block of long-term care insurance was $1.2 billion and $1.6 billion, respectively.

A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance loss recognition testing margin was as follows for the periods presented:

Acquired blockIncrease (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates and assumptions used in loss recognition testing:
Present value of expected future benefits$1,900$2,118$(218)(10)%
Discount rate assumption5.91%6.06%(15)0/000(2)%

Our acquired block of long-term care insurance had positive margin of approximately $100 million to $150 million as of December 31, 2022 compared to approximately $50 million to $100 million as of December 31, 2021. The margin in 2022 increased primarily from updates to claim severity and incidence, partially offset by lower investment yields due to portfolio rebalancing resulting in an overall reduction in the interest rate used to discount the insurance liabilities.

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 long-term care insurance loss recognition testing margin:

(Amounts in millions)Acquired block
Sensitivities on loss recognition testing margin: (1)
5% relative increase in future claim costs$(95)
Discount rate decrease of 25 basis points (2)$(25)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another. For example, the increase in claim costs does not include any incremental adverse impacts from a potential decrease in the discount rate.
Column 1Column 2
(2)The 25 basis point decrease in the discount rate refers to a reduction in our portfolio yields.

129

Table of Contents

Due to the age of our acquired block, it would not benefit significantly from future in-force rate actions; therefore, in-force rate actions are excluded from the significant estimates and assumptions disclosed above.

Term and whole life insurance

Similar to our long-term care insurance products, we annually perform loss recognition testing for the liability for future policy benefits for our term and whole life insurance products in the aggregate, excluding our acquired block, which are tested separately. As of December 31, 2022 and 2021, the liability for future policy benefits associated with our term and whole life insurance products was $1.9 billion and $2.0 billion, respectively.

The risks we face in these products mostly include adverse variations in mortality and lapse assumptions. A summary of certain of our significant estimates used in the calculation of our term and whole life insurance block, excluding the acquired block, loss recognition testing margin was as follows for the periods presented:

Other block (excluding the acquired block)Increase (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates used in loss recognition testing:
Total present value of expected future premiums$2,404$2,612$(208)(8)%
Total present value of expected death benefits and expenses$1,931$2,109$(178)(8)%

As of December 31, 2022 and 2021, we had margin of approximately $300 million to $800 million and a DAC balance of $0.7 billion and $0.8 billion, respectively, on our term and whole life insurance products, excluding the acquired block. The decrease in both the present value of expected future premiums and death benefits and expenses in 2022 was primarily attributable to elevated lapses in 2022.

A summary of certain of our significant estimates used in the calculation of our acquired term and whole life insurance block loss recognition testing margin was as follows for the periods presented:

Acquired blockIncrease (decrease) and percentage change
December 31,
(Amounts in millions)202220212022 vs. 2021
Select estimates used in loss recognition testing:
Total present value of expected future premiums$491$506$(15)(3)%
Total present value of expected death benefits and expenses$302$317$(15)(5)%

As of December 31, 2022 and 2021, we had margin of approximately $100 million to $300 million and a PVFP balance of $69 million and $71 million, respectively, on our acquired block of term and whole life insurance products.

130

Table of Contents

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 term and whole life insurance loss recognition testing margin:

(Amounts in millions)Other block (excluding the acquired block)Acquired blockTotal
Sensitivities on loss recognition testing: (1)
2% higher mortality$(55)$(7)$(62)
10% increase in lapses$(252)$(40)$(292)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another.

The sensitivities in the table above are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products.

Single premium immediate annuities

As of December 31, 2022 and 2021, the liability for future policy benefits associated with our single premium immediate annuity products with life contingencies was $10.0 billion and $11.3 billion, respectively. We regularly review our assumptions for these products and perform loss recognition testing at least annually. In 2016, we had a premium deficiency in our single premium immediate annuity products that resulted in the write-off of the entire DAC balance associated with these products. Subsequent to 2016, additional premium deficiencies have occurred in our single premium immediate annuity products that resulted in the establishment of additional future policy benefit reserves and were reflected as losses in net income.

In 2022, 2021 and 2020, the results of our loss recognition testing did not result in a premium deficiency; therefore, our liability for future policy benefits was sufficient, with a margin of approximately $25 million as of December 31, 2022 compared to approximately $85 million as of December 31, 2021. The decrease in the margin was primarily due to lower investment performance in relation to expected benefit payments and a reduction in the discount rate in 2022.

A summary of certain of our significant estimates and assumptions used in the calculation of our single premium immediate annuity products loss recognition testing margin was as follows for the periods presented:

December 31,Increase (decrease) and percentage change
(Amounts in millions)202220212022 vs. 2021
Select estimates and assumptions used in loss recognition testing:
Total present value of expected benefits and expenses$2,920$3,430$(510)(15)%
Reported investment yield5.54%5.79%(25)0/000(4)%

The decrease in the present value of expected benefits and expenses in 2022 was principally related to benefit payments and lower assumed reserves as a result of a third-party recapture of $374 million of certain single premium immediate annuity contracts in 2022, partially offset by the lower discount rate largely due to yield curve inversion during 2022.

131

Table of Contents

The following sensitivities reflect hypothetical changes to certain of our significant estimates and assumptions and the associated impact it would have on our 2022 single premium immediate annuity products loss recognition testing margin:

(Amounts in millions)Single premium immediate annuity products
Sensitivities on loss recognition testing: (1)
2% lower mortality$(19)
10 basis point reduction in investment yields$(24)
Column 1Column 2
(1)The margin impacts are each discrete and do not reflect the impact one factor may have on another.

Policyholder account balances

The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future claims experience, which includes assumptions for insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.

We perform an annual review of assumptions for our universal and term universal life insurance products, typically in the fourth quarter. Our 2022 review resulted in a decrease in the liability for policyholder account balances of $37 million, with a corresponding pre-tax benefit recorded to net income, largely associated with higher interest rates. Our 2021 review resulted in an increase in the liability for policyholder account balances of $87 million, with a corresponding pre-tax loss recorded to net income, predominantly driven by higher pre-COVID-19 mortality. Other assumption updates mostly focused on long-term interest rate trends. Our 2020 review resulted in a decrease in the liability for policyholder account balances of $118 million, with a corresponding pre-tax benefit recorded to net income, primarily due to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products.

As of December 31, 2022 and 2021, we had DAC of $236 million and $—, respectively, and total policyholder account balances including reserves in excess of the contract value of $8.1 billion and $9.0 billion, respectively, related to our universal and term universal life insurance products. The increase in DAC and decrease in policyholder account balances in 2022 compared to 2021 was primarily attributable to a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. As of December 31, 2022, for our universal and term universal life insurance products, we estimate that a 100 basis point reduction in interest rates from the December 31, 2022 level, or 2% higher mortality, scenarios that we consider to be reasonably possible given historical changes in market conditions and experience on these products, would result in a loss recorded to net income (loss) of approximately $40 million and $42 million, respectively. Adverse experience in persistency could also result in the impairment of PVFP associated with these products as well as the establishment of higher additional benefit reserves. Any favorable changes in these assumptions would result in a reduction in the liability for policyholder account balances.

Liability for policy and contract claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been

132

Table of Contents

reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).

The following table sets forth our recorded liability for policy and contract claims as of December 31:

(Amounts in millions)20222021
U.S. Life Insurance segment:
Long-term care insurance$11,380$10,861
Life insurance299308
Fixed annuities1614
Enact segment519641
Runoff segment148
Other mortgage insurance (1)69
Total liability for policy and contract claims$12,234$11,841
Column 1Column 2
(1)Amounts included in Corporate and Other activities.

Long-term care insurance

The liability for policy and contract claims, also known as claim reserves, for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include investment returns, health care experience, insured mortality, insured morbidity and expenses. Our discount rate assumption assumes a static discount rate in line with our current portfolio yield.

We review our assumptions and methodologies relating to our claim reserves for our long-term care insurance business annually in the fourth quarter. In the fourth quarter of 2022, as part of our review, we considered emerging experience particularly in mortality and benefit utilization, including the impact of increased cost of care due to inflation. Based on the review of our assumptions and methodologies, we did not make any significant changes to our claim reserves in 2022. During the fourth quarter of 2021, we did not make any significant changes to the assumptions or methodologies relating to our claim reserves based on our review, other than routine updates to investment returns as we typically do each quarter. These updates did not have a significant impact on claim reserve levels. As experience has emerged in the past, we have made resulting changes to our assumptions that have had a material impact on our results of operations and financial position. Our experience will continue to emerge and as a result there is a potential for future assumption reviews to result in further updates.

Mortgage insurance

Estimates of mortgage insurance reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions developed based on past experience and the expectation of future development. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loan moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the reserve for losses associated with the potential claim may also

133

Table of Contents

increase. These inherently judgmental assumptions are established in a respective geography based on historical and expected experience. Enact Holdings has established processes, as well as contractual rights, to ensure it receives timely information from loan servicers to aid in the establishment of its estimates. In addition, when Enact Holdings has obtained sufficient facts and circumstances through its investigative process, it has the unilateral right under its master policies and at law to rescind coverage on the underlying loan certificate as if coverage never existed. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, loss reserves are not established for future claims on insured loans that are not currently in default.

Management of Enact Holdings reviews the loss reserves quarterly for adequacy, and if necessary, updates the assumptions used for estimating and calculating such reserves based on actual experience and historical frequency of claim and severity of loss rates that are applied to the current population of delinquencies. Factors considered in establishing loss reserves include claim frequency patterns (reflecting the loss mitigation actions on such claim patterns), the aged category of the delinquency (i.e., age and progression of delinquency to claim), the severity of loss and loan coverage percentage. The establishment of Enact Holdings’ mortgage insurance loss reserves is subject to inherent uncertainty and requires judgment. The actual amount of the claim payments may vary significantly from the loss reserve estimates. Enact Holdings’ estimates could be adversely affected by several factors, including but not limited to, the development of COVID-19 delinquencies, a deterioration of regional or national economic conditions leading to a reduction in borrowers’ income and thus their ability to make mortgage payments, a drop in housing values that could expose Enact Holdings to greater loss on resale of properties obtained through foreclosure proceedings, extended foreclosure timelines and an adverse change in the effectiveness of loss mitigation actions that could result in an increase in the frequency of expected claim rates. Enact Holdings’ estimates are also affected by the extent of fraud and misrepresentation that are uncovered in the loans that are insured and the coverage upon which Enact Holdings has consequently rescinded or may rescind going forward. Enact Holdings’ loss reserving methodology includes estimates of the number of loans in its delinquency inventory that will be rescinded or modified, as well as estimates of the number of loans for which coverage may be reinstated under certain conditions following a rescission action.

In considering the potential sensitivity of the factors underlying Enact Holdings’ best estimate of its mortgage insurance reserves for losses, it is possible that even a relatively small change in estimated delinquency-to-claim rate (“frequency”) or a relatively small percentage change in estimated claim amount (“severity”) could have a significant impact on reserves and, correspondingly, on results of operations. For example, based on Enact Holdings’ actual experience during the three-year period ended December 31, 2022, a quarterly change of 6% in its average frequency reserve factor would change the gross loss reserve amount for such quarter by approximately $80 million and a change of 6% in its average severity reserve factor would change the gross loss reserve amount for such quarter by approximately $26 million.

Deferred acquisition costs. DAC represents costs that are directly related to the successful acquisition of new and renewal insurance policies and investment contracts which are deferred and amortized over the estimated life of the related insurance policies. These costs primarily include commissions in excess of ultimate renewal commissions and underwriting and contract and policy issuance expenses for policies successfully acquired. DAC is amortized to expense in relation to the anticipated recognition of premiums or gross profits. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information.

The amortization of DAC for traditional long-duration insurance products (including term life insurance, life-contingent structured settlements and immediate annuities and long-term care insurance) is determined as a level proportion of premiums based on accepted actuarial methods and reasonable assumptions, including related to projected interest rates and investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, established when

134

Table of Contents

the contract or policy is issued. U.S. GAAP requires that assumptions for these types of products not be modified (or unlocked) unless recoverability testing, also known as loss recognition testing, deems them to be inadequate. Amortization is adjusted each period to reflect actual lapses or terminations. Accordingly, we could experience accelerated amortization of DAC and a charge to net income (loss) if policies lapse or terminate earlier than originally assumed, or if we fail recoverability testing.

Amortization of DAC for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for the unlocking of underlying key assumptions including interest rates, policyholder persistency or lapses, insured mortality and expenses. The estimation of expected gross profits is subject to change given the inherent uncertainty as to the underlying key assumptions employed and the long duration of our policy or contract liabilities. Changes in expected gross profits reflecting the unlocking of underlying key assumptions could result in a material increase or decrease in the amortization of DAC depending on the magnitude of the change in underlying assumptions. Significant factors that could result in a material increase or decrease in DAC amortization for these products include material changes in withdrawal or lapse rates, investment spreads or mortality assumptions. For the years ended December 31, 2022, 2021 and 2020, key assumptions were unlocked in our U.S. Life Insurance and Runoff segments to reflect our current expectation of future investment spreads, lapse rates and mortality.

We review DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to net income (loss) is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserves plus the current estimate of expected future gross premiums and interest income for a line of business are less than the current estimate of expected future benefits and expenses (including any unamortized DAC), a charge to net income (loss) is recorded for additional DAC amortization or for increased benefit reserves. The evaluation of DAC recoverability is subject to inherent uncertainty and requires significant judgment and estimates to determine the present values of future premiums, estimated gross profits and expected benefits and expenses of our businesses. In 2022, 2021 and 2020, in connection with our review of DAC for recoverability, we wrote off $52 million, $117 million and $63 million, respectively, of DAC in our universal and term universal life insurance products principally due to lower future estimated gross profits.

The following table sets forth the increase (decrease) in amortization of DAC related to unlocking of underlying key assumptions by segment for the years ended December 31:

(Amounts in millions)202220212020
U.S. Life Insurance$(3)$2$48
Enact6
Runoff(2)(2)(2)
Total$(5)$$52

Impacts on DAC from assumption reviews

In the fourth quarter of 2020, as part of our annual review of assumptions, we increased DAC amortization by $48 million in our universal and term universal life insurance products predominantly due to changes in expected gross profits driven mostly by lower projected cost of insurance assessments on our universal life insurance products and a model refinement in our term universal life insurance product related to persistency and grace period timing.

See notes 2 and 6 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to DAC.

135

Table of Contents

Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.

The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening of credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. As well, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investments portfolio.

Estimates of fair value for fixed maturity securities are obtained primarily from industry-standard pricing models utilizing observable market inputs. For our less liquid securities, such as our privately placed securities, we utilize independent market data to employ alternative valuation methods commonly used in the financial services industry to estimate fair value. These securities are categorized into a three-level hierarchy based on the observability of the inputs used in estimating the fair value.

Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2022, 6% of our total fixed maturity securities related to Level 3 private fixed maturities valued using internal pricing models. See notes 2, 4 and 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.

The following tables summarize the primary sources of data considered when determining fair value of each class of fixed maturity securities as of December 31:

2022
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$41,113$$41,113$
Broker quotes250250
Internal models5,2202,2802,940
Total fixed maturity securities$46,583$$43,393$3,190
2021
(Amounts in millions)TotalLevel 1Level 2Level 3
Fixed maturity securities:
Pricing services$53,852$$53,852$
Broker quotes312312
Internal models6,3162,8203,496
Total fixed maturity securities$60,480$$56,672$3,808

136

Table of Contents

Consolidated Balance Sheets

Total assets. Total assets decreased $12,729 million from $99,171 million as of December 31, 2021 to $86,442 million as of December 31, 2022.

Column 1Column 2Column 3Column 4
Cash, cash equivalents and invested assets decreased $13,102 million primarily from decreases of $13,897 million and $254 million in fixed maturity securities and other invested assets, respectively, partially offset by increases of $431 million, $228 million and $180 million in limited partnerships, cash, cash equivalents and restricted cash, and commercial mortgage loans, respectively. The decrease in fixed maturity securities was predominantly related to a decrease in the fair value of our available-for-sale fixed maturities due to rising interest rates and from net sales and maturities in 2022. The decrease in other invested assets was largely driven by lower derivative valuations due to an increase in interest rates. These decreases were partially offset by increases in limited partnerships mainly from capital calls and commercial mortgage loans primarily from originations outpacing repayments in 2022, as well as an increase in cash, cash equivalents and restricted cash. The increase in cash, cash equivalents and restricted cash was largely attributable to net sales and maturities of fixed maturity securities, partially offset by net withdrawals from our investment contracts and the repurchase and early redemption of Genworth Holdings’ senior notes due in 2024 of $282 million in 2022.
Column 1Column 2Column 3Column 4
DAC increased $1,054 million principally attributable to a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. The reduction in shadow accounting adjustments increased DAC by approximately $1,332 million, mostly in our long-term care insurance business, with an offsetting amount recorded in accumulated other comprehensive income (loss). This increase was partially offset by amortization and by DAC impairments of $52 million in our universal and term universal life insurance products recorded in connection with our periodic reviews of DAC for recoverability.
Column 1Column 2Column 3Column 4
Reinsurance recoverable decreased $378 million mainly attributable to the runoff of our structured settlement products ceded to UFLIC.
Column 1Column 2Column 3Column 4
Deferred tax asset increased $1,225 million largely due to the change in unrealized gains (losses) on investments and derivatives due to rising interest rates, partially offset by the utilization of net operating losses in 2022. In addition, given the change in our unrealized gains (losses) on our fixed maturity securities and forward starting swaps due to rising interest rates and the corresponding reduction in the amount of unrealized capital gains expected to be available in the future to offset our capital loss carryforwards and other capital deferred tax assets, we recorded an additional valuation allowance of $200 million in 2022 through accumulated other comprehensive income (loss) related to deferred tax assets that would produce capital losses.
Column 1Column 2Column 3Column 4
Separate account assets (and liabilities) decreased $1,649 million primarily due to unfavorable equity market performance and surrenders in 2022.

Total liabilities. Total liabilities decreased $7,202 million from $82,905 million as of December 31, 2021 to $75,703 million as of December 31, 2022.

Column 1Column 2Column 3Column 4
Future policy benefits decreased $3,464 million primarily driven by a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. The reduction in shadow accounting adjustments decreased future policy benefits by approximately $3,181 million, mostly in our long-term care insurance business, with an offsetting amount recorded in accumulated other comprehensive income (loss). The decrease was also attributable to reduced benefits of $668 million related to in-force rate actions approved and implemented, which included policyholder benefit reduction elections made in connection with legal settlements in our long-term care insurance business. In addition, we released $371 million of future policy benefits in connection with the recapture of certain single premium immediate annuity contracts by a third

137

Table of Contents

Column 1Column 2
party in 2022. These decreases were partially offset by aging of our long-term care insurance in-force block and higher incremental reserves of $405 million recorded in connection with an accrual for profits followed by losses in 2022.
Column 1Column 2Column 3Column 4
Policyholder account balances decreased $2,241 million largely driven by a reduction in shadow accounting adjustments associated with an increase in interest rates in 2022. The reduction in shadow accounting adjustments decreased policyholder account balances by approximately $908 million in our universal life insurance products, with an offsetting amount recorded in accumulated other comprehensive income (loss). The decrease was also attributable to surrenders and benefits in our single premium deferred annuity products in 2022.
Column 1Column 2Column 3Column 4
Liability for policy and contract claims increased $393 million primarily related to our long-term care insurance business largely attributable to new claims and claim severity as a result of the aging of the in-force block, partially offset by claim terminations and pending claims that did not result in an active claim in 2022. The increase was also partially offset by a decrease in our Enact segment from net favorable reserve adjustments of $268 million primarily related to COVID-19 delinquencies from 2020 and 2021 curing at levels above original reserve expectations, partially offset by reserve strengthening related to 2022 delinquencies given uncertainty in the current economic environment. The net favorable reserve adjustments were partially offset by new delinquencies in 2022.
Column 1Column 2Column 3Column 4
Other liabilities increased $161 million largely driven by a decline in derivative valuations due to an increase in interest rates, partially offset by lower counterparty collateral held from the decline in derivative valuations in 2022.
Column 1Column 2Column 3Column 4
Long-term borrowings decreased $288 million mostly attributable to the repurchase and early redemption of Genworth Holdings’ February 2024 senior notes in 2022. See note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional details.

Total equity. Total equity decreased $5,527 million from $16,266 million as of December 31, 2021 to $10,739 million as of December 31, 2022.

Column 1Column 2Column 3Column 4
We reported net income available to Genworth Financial, Inc.’s common stockholders of $609 million for the year ended December 31, 2022.
Column 1Column 2Column 3Column 4
Unrealized gains (losses) on investments and derivatives qualifying as hedges decreased $5,286 million and $825 million, respectively, primarily from an increase in interest rates in 2022.
Column 1Column 2Column 3Column 4
Treasury stock increased $64 million primarily due to the repurchase of Genworth Financial’s common stock, at cost, in connection with a share repurchase program.

Liquidity and Capital Resources

Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.

138

Table of Contents

Overview of cash flows—Genworth and subsidiaries

The following table sets forth our condensed consolidated cash flows for the years ended December 31:

(Amounts in millions)202220212020
Net cash from operating activities$1,049$437$1,960
Net cash from (used by) investing activities733896(1,153)
Net cash used by financing activities(1,554)(2,419)(1,507)
Net increase (decrease) in cash before foreign exchange effect$228$(1,086)$(700)

Our principal sources of cash include sales of our products and services, income from our investment portfolio and proceeds from sales of investments. As an insurance business, we typically generate positive cash flows from operating activities, as premiums collected from our insurance products and income received from our investments typically exceed policy acquisition costs, benefits paid, redemptions and operating expenses. Our cash flows from operating activities are affected by the timing of premiums, fees and investment income received and benefits and expenses paid. Positive cash flows from operating activities are then invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flow, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; deposits to and maturities of funding agreements; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the acquisition of treasury stock and other capital transactions.

We had higher cash inflows from operating activities in 2022 primarily from lower payments to AXA, partially offset by higher net cash disbursements in connection with the return of cash collateral received from counterparties under our derivative contracts. In addition, in 2021, we made an initial cash payment of $360 million in connection with a new reinsurance agreement under which we ceded certain term life insurance policies. In 2022, we paid AXA $31 million related to estimated future claims, compared to payments of $561 million in 2021 comprised of the full repayment of a secured promissory note issued to AXA of $543 million, including accrued interest, and an $18 million settlement payment associated with underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

We had lower cash inflows from investing activities in 2022 mainly due to net proceeds received in 2021 from the sale of Genworth Australia, partially offset by higher net sales and maturities of fixed maturity securities in 2022.

We had lower cash outflows from financing activities in 2022 principally from lower repayment and repurchase of long-term debt and lower net withdrawals from our investment contracts, partially offset by net proceeds from the minority IPO of Enact Holdings in 2021. In 2022, Genworth Holdings repurchased $130 million and early redeemed $152 million principal balance of its senior notes originally due in February 2024 and repurchased $13 million principal amount of its senior notes due in 2034. In 2021, Genworth Holdings repurchased $91 million and $118 million principal amount of its senior notes due in August 2023 and February 2024, respectively, and early redeemed the remaining $309 million of its senior notes originally scheduled to mature in August 2023. Genworth Holdings also repurchased $146 million and early redeemed the remaining $513 million principal balance of its senior notes due in September 2021 and redeemed the $338 million principal balance of its senior notes due in February 2021.

Genworth—holding company liquidity

In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding

139

Table of Contents

company for their respective subsidiaries and do not have any significant operations of their own. Accordingly, our holding companies are highly dependent upon their respective subsidiaries to pay dividends and make other payments to meet their respective obligations. Moreover, management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt.

Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends from their respective subsidiaries, subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. Our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Although the business performance and financial results of our principal U.S. life insurance subsidiaries have improved significantly, as of December 31, 2022, they had negative unassigned surplus of approximately $849 million under statutory accounting and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors (including in the case of the payment of dividends to us, the approval of Enact Holdings’ independent capital committee) are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.

The primary uses of funds at Genworth Financial and Genworth Holdings include payment of principal, interest and other expenses on current and any future borrowings or other obligations (including payments to AXA associated with a settlement agreement reported as discontinued operations, payment of holding company general operating expenses (including employee benefits and taxes), payments under current and any future guarantees (including guarantees of certain subsidiary obligations), payment of amounts previously owed to GE under the Tax Matters Agreement, payments to subsidiaries (and, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, contributions to subsidiaries, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 13 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”

In November 2008, Genworth Financial’s Board of Directors suspended the payment of dividends to its shareholders and the repurchase of common stock under the Company’s stock repurchase program indefinitely. Given the significant improvement in the results of operations and financial position of Genworth Financial and its subsidiaries, and the $2.1 billion of debt reduction in 2021, on May 2, 2022, Genworth Financial’s Board of Directors authorized a share repurchase program under which Genworth Financial may repurchase up to $350 million of its outstanding Class A common stock. Pursuant to the program, during 2022, Genworth Financial repurchased 16,173,196 shares of its common stock at an average price of $3.94 per share for a total cash outlay of $64 million, including costs paid in connection with acquiring the shares. Genworth Financial also repurchased 5,912,297 shares from February 9, 2023 through February 24, 2023 of its common stock at an average price of $6.08 per share for a total cost of $36 million, leaving approximately $250 million that may yet be purchased under the share repurchase program. Future repurchases under the authorized program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future dividends from Genworth Financial’s ownership in Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated transactions, or by other means, including through 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.

Our future use of liquidity and capital will prioritize future strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases (as discussed above). With the early retirement of Genworth Holdings’ February 2024 debt in the third quarter of 2022, we achieved our deleveraging

140

Table of Contents

goal of reducing debt at Genworth Holdings to approximately $1.0 billion. As of December 31, 2022, Genworth Holdings had outstanding $887 million principal of long-term debt. We may from time to time seek to repurchase or redeem outstanding notes for cash (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise. We expect to provide capital to CareScout to help advance our senior care growth initiatives through fee-based services, advice, consulting and other products related to the needs of elderly Americans, as well as their caregivers and families. We will initially focus on care advice and service offerings that help consumers navigate the complex caregiving challenges in the market, which is less capital intensive than insurance product offerings.

As of December 31, 2022, Genworth Holdings had $307 million of unrestricted cash, cash equivalents and liquid assets. Given the early retirement in the third quarter of 2022 of its senior notes originally due in February 2024, no debt maturities are due until June 2034. For further information about Genworth Holdings’ borrowings, refer to note 12 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” In addition, in February 2022, Genworth Holdings paid AXA the majority of the remaining estimated unprocessed claims, and accordingly, we do not expect to pay AXA any significant amounts over the next twelve months.

We believe Genworth Holdings’ unrestricted cash, cash equivalents and liquid assets provide sufficient liquidity to meet its financial obligations over the next twelve months. However, we anticipate paying federal taxes starting in 2023 or 2024 due to projected taxable income and the utilization of our remaining net operating losses and foreign tax credits; therefore, we expect the amount of intercompany cash tax payments retained by Genworth Holdings from its subsidiaries to be lower starting in 2023 or 2024 as compared to the amounts received during 2021 and 2022. We also expect Genworth Holdings’ liquidity to be significantly impacted by the amounts and timing of future dividends and other forms of capital returns from Enact Holdings, which will be influenced by economic, regulatory factors and other conditions that affect its business. We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. For example, although interest rates have risen dramatically during 2022, we do not expect a significant impact on our liquidity given the reduction in Genworth Holdings’ debt, which will decrease our future debt service costs. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or from future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.

Enact Holdings continues to evaluate its capital allocation strategy to consistently support its existing policyholders, grow its mortgage insurance business, fund attractive new business opportunities and return capital to shareholders. To this end, on April 26, 2022, Enact Holdings’ board of directors approved the initiation of a quarterly cash dividend program. Pursuant to the program, Enact Holdings paid quarterly dividends beginning in the second quarter of 2022, and Genworth Holdings received $57 million in 2022 as the majority shareholder. In addition, Enact Holdings paid a special dividend in the fourth quarter of 2022 and Genworth Holdings received approximately $148 million as the majority shareholder. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial, and also be dependent on a variety of economic, market and business conditions, among other considerations.

On November 1, 2022, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings may repurchase up to $75 million of its outstanding common stock. Genworth Holdings has agreed to participate in order to maintain its overall ownership at its current level. Enact Holdings began share repurchases under the program in the fourth quarter of 2022. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Enact Holdings’ stock price and trading volume, and general business and market conditions, among other factors.

141

Table of Contents

Genworth Holdings—changes in liquidity

Genworth Holdings had $307 million and $331 million of cash and cash equivalents as of December 31, 2022 and 2021, respectively. Genworth Holdings also held $25 million in U.S. government securities as of December 31, 2021, which included approximately $3 million of restricted assets. The decrease in Genworth Holdings’ cash and cash equivalents was principally driven by the $282 million repurchase and early redemption of the principal balance of its senior notes originally due in February 2024, a $55 million payment to GE to satisfy its remaining obligation under the Tax Matters Agreement and the payment of unprocessed claims of $31 million to AXA, partially offset by intercompany cash tax payments received from its subsidiaries and dividends from Enact Holdings in 2022.

During 2022, 2021 and 2020, Genworth Holdings received cash dividends from Enact Holdings of $205 million, $163 million and $437 million, respectively. Dividends paid by Enact Holdings in 2022 and 2021 included a proportionate dividend distribution to minority shareholders. Dividends received by Genworth Holdings in 2020 were from net proceeds received from Enact Holdings’ senior notes issued in August 2020. During the years ended December 31, 2021 and 2020, Genworth Holdings received cash dividends from its international subsidiaries of $370 million and $11 million, respectively. Dividends received by Genworth Holdings in 2021 included the net proceeds from the sale of Genworth Australia.

There were no dividends paid to Genworth Holdings by its domestic life insurance subsidiaries during the years ended December 31, 2022, 2021 and 2020. As discussed above, we do not expect these subsidiaries to pay dividends for the foreseeable future.

Capital resources and financing activities

Our current capital resource plans do not include any additional debt offerings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of their respective subsidiaries to pay dividends and make other payments and distributions to each of them and to meet their obligations,” and “—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.” These risks may be exacerbated by the economic impact of current elevated interest rates and the affordability of homes.

On June 30, 2022, Enact Holdings entered into a credit agreement with a syndicate of lenders that provides for a five-year unsecured revolving credit facility in the initial aggregate principal amount of $200 million, including the ability for Enact Holdings to increase the commitments under the credit facility on an uncommitted basis, by an additional aggregate principal amount of up to $100 million. Any borrowings under Enact Holdings’ credit facility will bear interest at a per annum rate equal to a floating rate tied to a standard short-term borrowing index selected at Enact Holdings’ option, plus an applicable margin, pursuant to the terms of the credit agreement. The applicable margin is based on Enact Holdings’ ratings established by certain debt rating agencies for its outstanding debt. Enact Holdings may use borrowings under its credit facility for working capital needs and general corporate purposes, including the execution of dividends to its shareholders and capital contributions to its insurance subsidiaries. Enact Holdings’ credit facility includes customary representations, warranties, covenants, terms and conditions. As of December 31, 2022, Enact Holdings was in compliance with all covenants and the credit facility remained undrawn.

In the fourth quarter of 2022, Genworth Holdings repurchased $13 million principal amount of its 6.50% senior notes due in 2034 for a pre-tax gain of $1 million and paid accrued interest thereon.

On September 21, 2022, Genworth Holdings early redeemed its 4.80% senior notes originally scheduled to mature in February 2024. The senior notes were fully redeemed with a cash payment of $155 million, comprised

142

Table of Contents

of the outstanding principal balance of $152 million, accrued interest of $1 million and a make-whole premium of $2 million. Prior to the early redemption of its 4.80% senior notes due in February 2024, Genworth Holdings repurchased $130 million principal amount of the notes for a pre-tax loss of $4 million in the first half of 2022 and also repurchased $118 million for a pre-tax loss of $6 million in the fourth quarter of 2021, and paid accrued interest thereon.

On December 15, 2021, Genworth Holdings early redeemed its 4.90% senior notes originally scheduled to mature in August 2023. The senior notes were fully redeemed with a cash payment of $334 million, comprised of the outstanding principal balance of $309 million, accrued interest of $5 million and a make-whole premium of $20 million. Prior to the early redemption, Genworth Holdings repurchased $91 million principal amount of its 4.90% senior notes due in September 2021 for a pre-tax loss of $9 million and paid accrued interest thereon.

On July 21, 2021, Genworth Holdings early redeemed its 7.625% senior notes originally scheduled to mature in September 2021. The senior notes were fully redeemed with a cash payment of $532 million, comprised of the outstanding principal balance of $513 million, accrued interest of $13 million and a make-whole premium of $6 million. Prior to the early redemption, Genworth Holdings repurchased $146 million principal amount of its 7.625% senior notes due in September 2021 for a pre-tax loss of $4 million and paid accrued interest thereon.

Genworth Holdings paid its 7.20% senior notes with a principal balance of $338 million at maturity on February 16, 2021. Genworth Holdings’ 7.20% senior notes were fully redeemed with a cash payment of $350 million, comprised of the outstanding principal balance and accrued interest.

Regulated insurance subsidiaries

Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 17 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends and distributions are required to be submitted to an insurer’s domiciliary department of insurance for review. Based on estimated statutory results as of December 31, 2022, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $292 million in 2023 without affirmative regulatory approval. However, Enact Holdings may not pay dividends in 2023 at this level as they may need to retain capital for regulatory purposes and preserve capital for future growth or to meet capital requirements.

The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payment of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements. Given the challenging macroeconomic environment, during 2022, employee costs were higher driven in part by high inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care principally attributable to elevated inflation. These inflationary impacts have not had a significant impact to date; however, we will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity.

Given our insurance product mix, payments to policyholders for insurance benefits are generally consistent each year with the exception of products that provide long-duration coverage, such as long-term care insurance. For example, our current projections reflect average annual claim payments of approximately $2.5 billion over the next five years primarily driven by surrender and benefit payments associated with fixed annuity products. Actual claims experience on products that provide long-duration coverage typically emerge over many years, change over time and are difficult to accurately predict. Therefore, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Moreover, for long-duration

143

Table of Contents

coverage products, we generally assume a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. For example, in 2028 and thereafter, we assume approximately $96.9 billion of claims and benefit payments will be paid to policyholders or approximately 89% of our total undiscounted claims and benefit payments. These assumed payments are principally associated with our long-term care insurance products given their long-duration coverages. These amounts are derived from estimates and actuarial assumptions used in establishing our reserves; however, they have not been discounted to present value like our obligations to policyholders reported in our consolidated balance sheets in accordance with U.S. GAAP, where the liabilities are discounted consistent with the present value concept under accounting guidance related to accounting and reporting by insurance enterprises. Therefore, these undiscounted amounts significantly exceed the liabilities recorded in reserves for future policy benefits and the liability for policy and contract claims. These undiscounted amounts include estimated claims and benefits, policy surrender and commission obligations calculated consistent with U.S. GAAP on in-force long-duration insurance policies and investment contracts and also include estimated claims obligations on mortgage insurance policies in-force and amounts established for recourse and indemnification related to the contract underwriting business in our Enact segment. Due to the significance of the assumptions used in estimating our claim and benefit obligations, these assumed amounts could materially differ from actual results.

Our insurance subsidiaries have used cash flows from operations and investment activities to fund their liquidity requirements. Our insurance subsidiaries’ principal cash inflows from operating activities are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income and dividends and distributions from their subsidiaries. The principal cash inflows from investment activities result from maturities and repayments of investments and, as necessary, sales of invested assets.

Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2022, our total cash, cash equivalents and invested assets were $60.7 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2022.

Guarantees and other off-balance sheet commitments

Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.

Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2022, the risk in-force of active policies was approximately $950 million.

144

Table of Contents

Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes.

On March 1, 2021, Genworth Holdings entered into a guarantee agreement with Genworth Financial International Holdings, LLC (“GFIH”) whereby Genworth Holdings agreed to contribute additional capital to GFIH related to certain of its liabilities, or otherwise satisfy or discharge those liabilities. The liabilities include but are not limited to, claims and financial obligations or other liabilities of GFIH that existed immediately prior to the distribution of the net proceeds from the Genworth Australia sale. Pursuant to the agreement, Genworth Holdings paid AXA approximately €15 million ($18 million) in the second quarter of 2021 to settle amounts owed related to underwriting losses on a product sold by a distributor in our former lifestyle protection insurance business.

Genworth Financial and certain of its holding companies also provide guarantees to third parties for the performance of certain obligations of their subsidiaries. We estimate that our potential obligations under such guarantees were $69 million and $10 million as of December 31, 2022 and 2021, respectively. The potential obligations as of December 31, 2022 include amounts associated with leasing agreements related to our new headquarters office. For more information about our new headquarters office, see “Item 2—Properties.”

As of December 31, 2022, we were committed to fund $1,365 million in limited partnership investments, $70 million of bank loan investments which had not yet been drawn, $19 million in private placement investments and $5 million in commercial mortgage loan investments.

Supplemental Condensed Consolidating Financial Information

Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior and subordinated notes and the holders of the senior and subordinated notes, on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any, and interest on, and all other amounts payable under, the outstanding senior and subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior and subordinated notes indentures in respect of such senior and subordinated notes.

The following supplemental condensed consolidating financial information of Genworth Financial and its direct and indirect subsidiaries has been prepared pursuant to rules regarding the preparation of consolidating financial information of Regulation S-X, as amended by the SEC on March 2, 2020.

The supplemental condensed consolidating financial information presents the condensed consolidating balance sheet information as of December 31, 2022 and 2021 and the condensed consolidating income statement information, condensed consolidating comprehensive income statement information and condensed consolidating cash flow statement information for the years ended December 31, 2022 and 2021.

The supplemental condensed consolidating financial information reflects Genworth Financial (“Parent Guarantor”), Genworth Holdings (“Issuer”) and each of Genworth Financial’s other direct and indirect subsidiaries (the “All Other Subsidiaries”) on a combined basis, none of which guarantee the senior notes or subordinated notes, as well as the eliminations necessary to present Genworth Financial’s financial information on a consolidated basis and total consolidated amounts.

The accompanying supplemental condensed consolidating financial information is presented based on the equity method of accounting for all periods presented. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. Elimination entries include consolidating and eliminating entries for investments in subsidiaries and intercompany activity.

145

Table of Contents

The following table presents the condensed consolidating balance sheet information as of December 31, 2022:

ParentAll Other
(Amounts in millions)GuarantorIssuerSubsidiariesEliminationsConsolidated
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $50,834 and allowance for credit losses of $—)$$$46,583$$46,583
Equity securities, at fair value319319
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4)7,0327,032
Less: Allowance for credit losses(22)(22)
Commercial mortgage loans, net7,0107,010
Policy loans2,1392,139
Limited partnerships2,3312,331
Other invested assets566566
Investments in subsidiaries10,00810,256(20,264)
Total investments10,00810,25658,948(20,264)58,948
Cash, cash equivalents and restricted cash3071,4921,799
Accrued investment income643643
Deferred acquisition costs2,2002,200
Intangible assets241241
Reinsurance recoverable16,49516,495
Less: Allowance for credit losses(60)(60)
Reinsurance recoverable, net16,43516,435
Other assets388324415
Intercompany notes receivable2726(53)
Deferred tax assets62251,1131,344
Separate account assets4,4174,417
Total assets$10,017$10,903$85,839$(20,317)$86,442
Liabilities and equity
Liabilities:
Future policy benefits$$$38,064$$38,064
Policyholder account balances17,11317,113
Liability for policy and contract claims12,23412,234
Unearned premiums584584
Other liabilities771,6581,672
Intercompany notes payable26261(53)
Long-term borrowings8687431,611
Separate account liabilities4,4174,417
Liabilities related to discontinued operations448
Total liabilities3390574,818(53)75,703
Equity:
Common stock14(4)1
Additional paid-in capital11,86912,73418,203(30,937)11,869
Accumulated other comprehensive income (loss)(2,220)(2,220)(1,977)4,197(2,220)
Retained earnings3,098(516)(6,264)6,7803,098
Treasury stock, at cost(2,764)(2,764)
Total Genworth Financial, Inc.’s stockholders’ equity9,9849,9989,966(19,964)9,984
Noncontrolling interests1,055(300)755
Total equity9,9849,99811,021(20,264)10,739
Total liabilities and equity$10,017$10,903$85,839$(20,317)$86,442

146

Table of Contents

The following table presents the condensed consolidating balance sheet information as of December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Assets
Investments:
Fixed maturity securities available-for-sale, at fair value (amortized cost of $52,611 and allowance for credit losses of $—)$$$60,480$$60,480
Equity securities, at fair value198198
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $4)6,8566,856
Less: Allowance for credit losses(26)(26)
Commercial mortgage loans, net6,8306,830
Policy loans2,0502,050
Limited partnerships1,9001,900
Other invested assets27793820
Investments in subsidiaries15,51715,626(31,143)
Total investments15,51715,65372,251(31,143)72,278
Cash, cash equivalents and restricted cash3311,2401,571
Accrued investment income647647
Deferred acquisition costs1,1461,146
Intangible assets143143
Reinsurance recoverable16,86816,868
Less: Allowance for credit losses(55)(55)
Reinsurance recoverable, net16,81316,813
Other assets5207176388
Intercompany notes receivable151(16)
Deferred tax assets4555(440)119
Separate account assets6,0666,066
Total assets$15,526$16,761$98,043$(31,159)$99,171
Liabilities and equity
Liabilities:
Future policy benefits$$$41,528$$41,528
Policyholder account balances19,35419,354
Liability for policy and contract claims11,84111,841
Unearned premiums672672
Other liabilities4641,4431,511
Intercompany notes payable1213(16)
Long-term borrowings1,1597401,899
Separate account liabilities6,0666,066
Liabilities related to discontinued operations30434
Total liabilities161,25481,651(16)82,905
Equity:
Common stock14(4)1
Additional paid-in capital11,85812,72418,135(30,859)11,858
Accumulated other comprehensive income (loss)3,8613,8613,906(7,767)3,861
Retained earnings2,490(1,078)(6,709)7,7872,490
Treasury stock, at cost(2,700)(2,700)
Total Genworth Financial, Inc.’s stockholders’ equity15,51015,50715,336(30,843)15,510
Noncontrolling interests1,056(300)756
Total equity15,51015,50716,392(31,143)16,266
Total liabilities and equity$15,526$16,761$98,043$(31,159)$99,171

147

Table of Contents

The following table presents the condensed consolidating income statement information for the year ended December 31, 2022:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Revenues:
Premiums$$$3,719$$3,719
Net investment income23,1443,146
Net investment gains (losses)(17)(17)
Policy fees and other income1660(2)659
Total revenues37,506(2)7,507
Benefits and expenses:
Benefits and other changes in policy reserves4,2424,242
Interest credited503503
Acquisition and operating expenses, net of deferrals3151,3351,371
Amortization of deferred acquisition costs and intangibles307307
Interest expense5553(2)106
Total benefits and expenses31606,440(2)6,529
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries(31)(57)1,066978
Provision (benefit) for income taxes(3)(15)257239
Equity in income of subsidiaries637685(1,322)
Income from continuing operations609643809(1,322)739
Income (loss) from discontinued operations, net of taxes(4)4
Net income609639813(1,322)739
Less: net income from continuing operations attributable to noncontrolling interests130130
Less: net income from discontinued operations attributable to noncontrolling interests
Net income available to Genworth Financial, Inc.’s common stockholders$609$639$683$(1,322)$609

148

Table of Contents

The following table presents the condensed consolidating income statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Revenues:
Premiums$$$3,435$$3,435
Net investment income(3)3,3733,370
Net investment gains (losses)323323
Policy fees and other income(1)7032704
Total revenues(3)(1)7,83427,832
Benefits and expenses:
Benefits and other changes in policy reserves4,3834,383
Interest credited508508
Acquisition and operating expenses, net of deferrals25441,1541,223
Amortization of deferred acquisition costs and intangibles377377
Interest expense(1)109502160
Total benefits and expenses241536,47226,651
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries(27)(154)1,3621,181
Provision (benefit) for income taxes(1)(33)297263
Equity in income of subsidiaries9301,041(1,971)
Income from continuing operations9049201,065(1,971)918
Income from discontinued operations, net of taxes131427
Net income9049331,079(1,971)945
Less: net income from continuing operations attributable to noncontrolling interests3333
Less: net income from discontinued operations attributable to noncontrolling interests88
Net income available to Genworth Financial, Inc.’s common stockholders$904$933$1,038$(1,971)$904

149

Table of Contents

The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2022:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Net income$609$639$813$(1,322)$739
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses(5,286)(5,286)(5,184)10,384(5,372)
Net unrealized gains (losses) on securities with an allowance for credit losses
Derivatives qualifying as hedges(825)(825)(815)1,640(825)
Foreign currency translation and other adjustments303030(60)30
Total other comprehensive income (loss)(6,081)(6,081)(5,969)11,964(6,167)
Total comprehensive loss(5,472)(5,442)(5,156)10,642(5,428)
Less: comprehensive income attributable to noncontrolling interests4444
Total comprehensive loss available to Genworth Financial, Inc.’s common stockholders$(5,472)$(5,442)$(5,200)$10,642$(5,472)

The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Net income$904$933$1,079$(1,971)$945
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities without an allowance for credit losses(334)(335)(371)670(370)
Net unrealized gains (losses) on securities with an allowance for credit losses666(12)6
Derivatives qualifying as hedges(186)(186)(215)401(186)
Foreign currency translation and other adjustments(24)(24)14947148
Total other comprehensive income (loss)(538)(539)(431)1,106(402)
Total comprehensive income366394648(865)543
Less: comprehensive income attributable to noncontrolling interests177177
Total comprehensive income available to Genworth Financial, Inc.’s common stockholders$366$394$471$(865)$366

150

Table of Contents

The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2022:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Cash flows from (used by) operating activities:
Net income$609$639$813$(1,322)$739
Less (income) loss from discontinued operations, net of taxes4(4)
Adjustments to reconcile net income to net cash from operating activities:
Equity in income from subsidiaries(637)(685)1,322
Dividends from subsidiaries205(205)
Amortization of fixed maturity securities discounts and premiums3(157)(154)
Net investment (gains) losses1717
Charges assessed to policyholders(596)(596)
Acquisition costs deferred
Amortization of deferred acquisition costs and intangibles307307
Deferred income taxes(6)21922235
Derivative instruments, limited partnerships and other5(340)(335)
Stock-based compensation expense271037
Change in certain assets and liabilities:
Accrued investment income and other assets21(164)(161)
Insurance reserves863863
Current tax liabilities240(43)(1)
Other liabilities, policy and contract claims and other policy-related balances15(1)115129
Cash used by operating activities—discontinued operations(31)(31)
Net cash from operating activities123996381,049
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities2,7052,705
Commercial mortgage loans759759
Limited partnerships and other invested assets185185
Proceeds from sales of investments:
Fixed maturity and equity securities2,6582,658
Purchases and originations of investments:
Fixed maturity and equity securities(4,035)(4,035)
Commercial mortgage loans(958)(958)
Limited partnerships and other invested assets(645)(645)
Short-term investments, net25(2)23
Policy loans, net4141
Intercompany notes receivable, net(99)6237
Capital contributions to subsidiaries(3)(6)9
Net cash from (used by) investing activities(3)(80)77937733
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts606606
Withdrawals from universal life and investment contracts(1,668)(1,668)
Repayment and repurchase of long-term debt(297)(297)
Intercompany notes payable, net649(36)(37)
Treasury stock acquired in connection with share repurchases(64)(64)
Dividends paid to noncontrolling interests(46)(46)
Other, net(9)(55)(21)(85)
Net cash used by financing activities(9)(343)(1,165)(37)(1,554)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net change in cash, cash equivalents and restricted cash(24)252228
Cash, cash equivalents and restricted cash at beginning of period3311,2401,571
Cash, cash equivalents and restricted cash at end of period3071,4921,799
Less cash, cash equivalents and restricted cash of discontinued operations at end of period
Cash, cash equivalents and restricted cash of continuing operations at end of period$$307$1,492$$1,799

151

Table of Contents

The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2021:

(Amounts in millions)Parent GuarantorIssuerAll Other SubsidiariesEliminationsConsolidated
Cash flows from (used by) operating activities:
Net income$904$933$1,079$(1,971)$945
Less income from discontinued operations, net of taxes(13)(14)(27)
Adjustments to reconcile net income to net cash from (used by) operating activities:
Equity in income from subsidiaries(930)(1,041)1,971
Dividends from subsidiaries552(552)
Amortization of fixed maturity securities discounts and premiums6(182)(176)
Net investment (gains) losses(323)(323)
Charges assessed to policyholders(620)(620)
Acquisition costs deferred(8)(8)
Amortization of deferred acquisition costs and intangibles377377
Deferred income taxes341(51)290
Derivative instruments, limited partnerships and other75(434)(359)
Stock-based compensation expense4040
Change in certain assets and liabilities:
Accrued investment income and other assets(1)9(137)(129)
Insurance reserves642642
Current tax liabilities(5)17(46)(34)
Other liabilities, policy and contract claims and other policy-related balances(13)(40)363310
Cash from (used by) operating activities-discontinued operations(564)73(491)
Net cash from (used by) operating activities(5)275167437
Cash flows from (used by) investing activities:
Proceeds from maturities and repayments of investments:
Fixed maturity securities4,1624,162
Commercial mortgage loans874874
Limited partnerships and other invested assets255255
Proceeds from sales of investments:
Fixed maturity and equity securities2,2732,273
Purchases and originations of investments:
Fixed maturity and equity securities(5,216)(5,216)
Commercial mortgage loans(963)(963)
Limited partnerships and other invested assets(767)(767)
Short-term investments, net1818
Policy loans, net5757
Intercompany notes receivable, net4(1)(3)
Capital contributions to subsidiaries(2)2
Proceeds from sale of business, net of cash transferred270270
Cash used by investing activities-discontinued operations(67)(67)
Net cash from (used by) investing activities(2)4897(3)896
Cash flows from (used by) financing activities:
Deposits to universal life and investment contracts669669
Withdrawals from universal life and investment contracts(2,071)(2,071)
Repayment and repurchase of long-term debt(1,541)(1,541)
Intercompany notes payable, net121(16)3
Proceeds from the sale of subsidiary shares to noncontrolling interests529529
Dividends paid to noncontrolling interests(37)(37)
Other, net(5)(15)5232
Net cash from (used by) financing activities7(1,026)(1,403)3(2,419)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (includes $(1) related to discontinued operations)11
Net change in cash, cash equivalents and restricted cash(747)(338)(1,085)
Cash, cash equivalents and restricted cash at beginning of period1,0781,5782,656
Cash, cash equivalents and restricted cash at end of period3311,2401,571
Less cash, cash equivalents and restricted cash of discontinued operations at end of period
Cash, cash equivalents and restricted cash of continuing operations at end of period$$331$1,240$$1,571

152

Table of Contents

Genworth Financial’s and Genworth Holdings’ insurance subsidiaries are subject to oversight by applicable insurance laws and regulations as to the amount of dividends they may pay to their parent in any year, the purpose of which is to protect affected insurance policyholders and contractholders, not stockholders. Enact Holdings’ ability to pay dividends is limited in part by such regulatory restrictions on its insurance subsidiaries. Dividends paid by Enact Holdings also include a proportionate distribution to minority shareholders. In addition, the GSEs have imposed certain restrictions on Enact Holdings with respect to the amount of holding company liquidity it must retain in connection with its outstanding debt. We believe the conditions set forth by the GSEs in connection to the restrictions were fully satisfied as of December 31, 2022 and expect the GSE Restrictions to be lifted in the first quarter of 2023, subject to GSE review and confirmation. Although the business performance and financial results of our principal U.S. life insurance subsidiaries have improved significantly, as of December 31, 2022, they had negative unassigned surplus of approximately $849 million under statutory accounting and as a result, we do not expect these subsidiaries to pay dividends for the foreseeable future. For additional information on significant restrictions on dividends by insurance subsidiaries of Genworth Financial and Genworth Holdings, see note 17 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data.”

For additional information on Genworth Financial’s capital management plans, including its share repurchase program, see “—Liquidity and Capital Resources.”

Back to the GNW company profile or the MD&A index.